{
  "schema_version": "0.1.0",
  "case_id": "HR-ET016",
  "record_classification": {
    "synthetic": true,
    "banner": "SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD",
    "real_historical_name": true,
    "public_release_status": "draft"
  },
  "identity": {
    "person_id": "ET016",
    "display_name": "Sun Yat-sen",
    "aliases": [
      "Sun Zhongshan",
      "Sun Yixian",
      "Sun Wen"
    ],
    "name_parts": {
      "given": [
        "Yat-sen"
      ],
      "family": "Sun",
      "family_first": true
    },
    "sex": "male",
    "era": "Early 20th Century",
    "nationality": "Chinese",
    "historical_dates": {
      "birth": {
        "preferred": {
          "iso": "1866-11-12",
          "display": "November 12, 1866",
          "precision": "day",
          "calendar": "gregorian"
        },
        "alternatives": [
          {
            "date": {
              "iso": "1866",
              "display": "1866",
              "precision": "year",
              "calendar": "gregorian"
            },
            "source_ids": [
              "SRC-0006"
            ],
            "resolution_status": "preferred",
            "note": "Roster year agrees with the museum biography."
          }
        ]
      },
      "death": {
        "preferred": {
          "iso": "1925-03-12",
          "display": "March 12, 1925",
          "precision": "day",
          "calendar": "gregorian"
        },
        "alternatives": [
          {
            "date": {
              "iso": "1925",
              "display": "1925",
              "precision": "year",
              "calendar": "gregorian"
            },
            "source_ids": [
              "SRC-0006"
            ],
            "resolution_status": "preferred",
            "note": "Roster year agrees with the cited sources."
          }
        ]
      }
    },
    "synthetic_identity": {
      "mrn": "HR-ET016-SYN",
      "ssn": "000-16-4183",
      "date_of_birth": "1968-11-12",
      "name_policy": "real_historical_name",
      "fictional_facility": "St. Posthumous Health Center",
      "fictional_primary_clinician": "Wen-Li Huang, MD",
      "fictional_consultant": {
        "name": "Raymond Choi, MD",
        "specialty": "Medical Oncology"
      }
    }
  },
  "historical_timeline": [
    {
      "event_id": "EVT-0001",
      "date": {
        "iso": "1866-11-12",
        "display": "November 12, 1866",
        "precision": "day",
        "calendar": "gregorian"
      },
      "summary": "Born in Cuiheng Village.",
      "claim_ids": [
        "CLM-0001"
      ]
    },
    {
      "event_id": "EVT-0002",
      "date": {
        "iso": "1879",
        "display": "About 1879 (age thirteen)",
        "precision": "year",
        "calendar": "gregorian"
      },
      "summary": "Began his studies in Honolulu.",
      "claim_ids": [
        "CLM-0002"
      ]
    },
    {
      "event_id": "EVT-0003",
      "date": {
        "iso": "1886",
        "display": "1886",
        "precision": "year",
        "calendar": "gregorian"
      },
      "summary": "Began studying Western medicine at the Boji Hospital in Guangzhou.",
      "claim_ids": [
        "CLM-0003"
      ]
    },
    {
      "event_id": "EVT-0004",
      "date": {
        "iso": "1887",
        "display": "1887",
        "precision": "year",
        "calendar": "gregorian"
      },
      "summary": "Entered the College of Medicine for Chinese in Hong Kong.",
      "claim_ids": [
        "CLM-0003"
      ]
    },
    {
      "event_id": "EVT-0005",
      "date": {
        "iso": "1892-07-23",
        "display": "July 23, 1892",
        "precision": "day",
        "calendar": "gregorian"
      },
      "summary": "Received his medical diploma at the college's first graduation ceremony.",
      "claim_ids": [
        "CLM-0003"
      ]
    },
    {
      "event_id": "EVT-0006",
      "date": {
        "iso": "1893",
        "display": "1893",
        "precision": "year",
        "calendar": "gregorian"
      },
      "summary": "Moved his medical practice from Macau to Guangzhou.",
      "claim_ids": [
        "CLM-0004"
      ]
    },
    {
      "event_id": "EVT-0007",
      "date": {
        "iso": "1894",
        "display": "1894",
        "precision": "year",
        "calendar": "gregorian"
      },
      "summary": "Founded the China Revival Society in Honolulu; left medicine for politics.",
      "claim_ids": [
        "CLM-0004",
        "CLM-0005"
      ]
    },
    {
      "event_id": "EVT-0008",
      "date": {
        "iso": "1905",
        "display": "1905",
        "precision": "year",
        "calendar": "gregorian"
      },
      "summary": "Founded the Chinese Revolutionary League in Tokyo.",
      "claim_ids": [
        "CLM-0005"
      ]
    },
    {
      "event_id": "EVT-0009",
      "date": {
        "iso": "1912-01-01",
        "display": "January 1, 1912",
        "precision": "day",
        "calendar": "gregorian"
      },
      "summary": "Became Provisional President of the Republic of China in Nanjing.",
      "claim_ids": [
        "CLM-0005"
      ]
    },
    {
      "event_id": "EVT-0010",
      "date": {
        "iso": "1924-01",
        "display": "January 1924",
        "precision": "month",
        "calendar": "gregorian"
      },
      "summary": "Presided over the First National Congress of the Kuomintang in Guangzhou.",
      "claim_ids": [
        "CLM-0005"
      ]
    },
    {
      "event_id": "EVT-0011",
      "date": {
        "iso": "1924-12-31",
        "display": "December 31, 1924",
        "precision": "day",
        "calendar": "gregorian"
      },
      "summary": "Arrived in Beijing in poor health.",
      "claim_ids": [
        "CLM-0006"
      ]
    },
    {
      "event_id": "EVT-0012",
      "date": {
        "iso": "1925-01-26",
        "display": "January 26, 1925",
        "precision": "day",
        "calendar": "gregorian"
      },
      "summary": "Admitted to the Peking Union Medical College Hospital; exploratory laparotomy found carcinoma involving the liver.",
      "claim_ids": [
        "CLM-0007",
        "CLM-0008",
        "CLM-0010"
      ]
    },
    {
      "event_id": "EVT-0013",
      "date": {
        "iso": "1925-02-18",
        "display": "February 18, 1925",
        "precision": "day",
        "calendar": "gregorian"
      },
      "summary": "Left the hospital against advice.",
      "claim_ids": [
        "CLM-0008"
      ]
    },
    {
      "event_id": "EVT-0014",
      "date": {
        "iso": "1925-03-12",
        "display": "March 12, 1925",
        "precision": "day",
        "calendar": "gregorian"
      },
      "summary": "Died in Beijing.",
      "claim_ids": [
        "CLM-0009",
        "CLM-0010"
      ]
    },
    {
      "event_id": "EVT-0015",
      "date": {
        "iso": "1925-03-13",
        "display": "March 13, 1925",
        "precision": "day",
        "calendar": "gregorian"
      },
      "summary": "Limited autopsy reported adenocarcinoma of the gallbladder with spread to the liver and beyond.",
      "claim_ids": [
        "CLM-0011"
      ]
    }
  ],
  "claims": [
    {
      "claim_id": "CLM-0001",
      "statement": "Sun Yat-sen was born on November 12, 1866, into an ordinary farming family in Cuiheng Village. He was called Dixiang in childhood and also had the names Mingwen, Deming and Rixin; the name Yat-sen came into use while he was in Japan.",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "clinical_interpretation": "The birth date used for the synthetic date of birth.",
      "source_links": [
        {
          "source_id": "SRC-0002",
          "relationship": "supports",
          "locator": "Introduction to the Museum of Dr. Sun Yat-sen"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    },
    {
      "claim_id": "CLM-0002",
      "statement": "He went to a private school at nine, studied in Honolulu from the age of thirteen, and returned home at seventeen.",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "clinical_interpretation": "Social history.",
      "source_links": [
        {
          "source_id": "SRC-0002",
          "relationship": "supports"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    },
    {
      "claim_id": "CLM-0003",
      "statement": "He began studying Western medicine at the Boji Hospital in Guangzhou in 1886 and in 1887 transferred to the College of Medicine for Chinese in Hong Kong, as one of its twelve students; his teachers included Patrick Manson. He was one of two students who passed the graduation examination in 1892 and received his diploma at the college's first graduation ceremony on July 23, 1892.",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "clinical_interpretation": "The anchor for the modern episode's physician-as-patient theme.",
      "source_links": [
        {
          "source_id": "SRC-0003",
          "relationship": "supports"
        },
        {
          "source_id": "SRC-0004",
          "relationship": "supports",
          "locator": "1886 Boji Hospital; 1887 Hong Kong College of Medicine for Chinese"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    },
    {
      "claim_id": "CLM-0004",
      "statement": "After graduating he practiced medicine in Macau, first at the Kiang Wu Hospital and then in a dispensary of his own, and then in Guangzhou, opening pharmacies that offered Chinese and Western medicines; about two years after graduating he gave up medicine for politics.",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "clinical_interpretation": "He practiced for about two years; the modern episode treats him as a physician by training who left practice decades ago.",
      "source_links": [
        {
          "source_id": "SRC-0003",
          "relationship": "supports",
          "locator": "settled in Macau; moved to Guangzhou in 1893; closed his practice about a year later"
        },
        {
          "source_id": "SRC-0004",
          "relationship": "supports",
          "locator": "practiced in Macau, Shiqi and Guangzhou"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    },
    {
      "claim_id": "CLM-0005",
      "statement": "In 1894 he founded the China Revival Society in Honolulu; in 1905 he founded the Chinese Revolutionary League in Tokyo; on New Year's Day 1912 he became Provisional President of the Republic of China in Nanjing; and in January 1924 he presided over the First National Congress of the Kuomintang in Guangzhou.",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "clinical_interpretation": "Social history: the anchor for the modern work as the leader of a political organization.",
      "source_links": [
        {
          "source_id": "SRC-0002",
          "relationship": "supports"
        },
        {
          "source_id": "SRC-0004",
          "relationship": "supports",
          "locator": "January 1924, First National Congress of the Kuomintang"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    },
    {
      "claim_id": "CLM-0006",
      "statement": "In the autumn of 1924, after the Beijing Coup, he was invited to Beijing to discuss state affairs, and he arrived in Beijing in poor health on the last day of 1924.",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "clinical_interpretation": "After the true-frame episode; history only.",
      "source_links": [
        {
          "source_id": "SRC-0002",
          "relationship": "supports"
        },
        {
          "source_id": "SRC-0005",
          "relationship": "supports",
          "locator": "On the last day of 1924, Sun Yat-sen, in poor health, came to Beijing"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    },
    {
      "claim_id": "CLM-0007",
      "statement": "Several months before his operation in January 1925 a mass had been noted in his right upper abdomen and was thought to be his liver; it grew larger shortly before surgery. At the preoperative examination he had no jaundice and not much loss of weight.",
      "evidence_grade": "D",
      "certainty": "probable",
      "clinical_interpretation": "The anchor for the modern presenting problem, a right upper quadrant mass. The month the mass was first noted is not recorded.",
      "source_links": [
        {
          "source_id": "SRC-0001",
          "relationship": "supports",
          "locator": "Summary of the PUMCH records"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    },
    {
      "claim_id": "CLM-0008",
      "statement": "He was admitted to the Peking Union Medical College Hospital on January 26, 1925, too ill to eat, and had an exploratory laparotomy that day by Adrian S. Taylor, the head of surgery, which found extensive involvement of the liver by carcinoma. He was treated with radium for the rest of his stay, left the hospital against advice on February 18, 1925, and was then treated by old-style Chinese doctors while his condition declined.",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "clinical_interpretation": "History only; after the true-frame episode.",
      "source_links": [
        {
          "source_id": "SRC-0001",
          "relationship": "supports"
        },
        {
          "source_id": "SRC-0005",
          "relationship": "supports",
          "locator": "hospitalized on January 26th 1925, at which point, he was too ill to eat"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    },
    {
      "claim_id": "CLM-0009",
      "statement": "He died in Beijing on March 12, 1925.",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "clinical_interpretation": "History only.",
      "source_links": [
        {
          "source_id": "SRC-0001",
          "relationship": "supports",
          "locator": "between 9:00 and 9:30 a.m."
        },
        {
          "source_id": "SRC-0002",
          "relationship": "supports"
        },
        {
          "source_id": "SRC-0004",
          "relationship": "supports"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    },
    {
      "claim_id": "CLM-0010",
      "statement": "His fatal illness has long been described as liver cancer, the diagnosis taken from the findings at the laparotomy; the museum at his birthplace states that he died of liver cancer.",
      "evidence_grade": "R",
      "certainty": "disputed",
      "clinical_interpretation": "Recorded as the traditional account; a later review of the autopsy report disputes a primary liver cancer (CLM-0011).",
      "source_links": [
        {
          "source_id": "SRC-0002",
          "relationship": "supports",
          "locator": "died of liver cancer in Beijing"
        },
        {
          "source_id": "SRC-0001",
          "relationship": "disputes",
          "locator": "mistakenly believed on the basis of the laparotomy observations"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    },
    {
      "claim_id": "CLM-0011",
      "statement": "A limited autopsy at the Peking Union Medical College Hospital on March 13, 1925, by James R. Cash, reported adenocarcinoma of the gallbladder with obstruction of the cystic duct, direct extension to the liver and diaphragm, and metastases to the lungs, peritoneum, ileum and colon, with healed cholecystitis, gallstones, generalized arteriosclerosis, healed calcified tuberculosis of the lungs, emphysema, ascites and roundworm infestation. A 2016 review concludes that gallbladder adenocarcinoma, not a primary liver cancer, caused his death.",
      "evidence_grade": "R",
      "certainty": "probable",
      "clinical_interpretation": "The anchor for the modern diagnosis: a gallbladder adenocarcinoma that invades the liver and presents as a liver mass. The review rests on the autopsy report; the original slides were not re-examined in the fetched source.",
      "source_links": [
        {
          "source_id": "SRC-0001",
          "relationship": "supports"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    }
  ],
  "sources": [
    {
      "source_id": "SRC-0001",
      "title": "Barth RF, Chen J. What did Sun Yat-sen really die of? A re-assessment of his illness and the cause of his death",
      "publisher": "Chinese Journal of Cancer 2016;35(1):81 (PMID 27586157)",
      "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC5009495/",
      "source_type": "scholarly",
      "published": "2016-09-02",
      "accessed": "2026-11-04",
      "rights_note": "Open-access letter (PMC5009495) summarizing the Peking Union Medical College Hospital clinical and autopsy records; facts used with citation."
    },
    {
      "source_id": "SRC-0002",
      "title": "Introduction to the Museum of Dr. Sun Yat-sen; Sun Yat-sen biography",
      "publisher": "Museum of Dr. Sun Yat-sen (Cuiheng)",
      "url": "https://sunyat-sen.org/index.php/portal/list/index.html?id=226",
      "source_type": "biography",
      "published": null,
      "accessed": "2026-11-04",
      "rights_note": "Museum biography pages (id=224 and id=226); facts used with citation."
    },
    {
      "source_id": "SRC-0003",
      "title": "Chow YYN. From medicine to politics (Dr Sun Yat-sen Oration)",
      "publisher": "The Hong Kong Practitioner 2007;29(7), Hong Kong College of Family Physicians",
      "url": "https://hkcfp.org.hk/Upload/HK_Practitioner/2007/hkp2007vol29jul/dr_sun_yat_sen_oration.html",
      "source_type": "scholarly",
      "published": "2007-07",
      "accessed": "2026-11-04",
      "rights_note": "Professional journal oration; facts used with citation."
    },
    {
      "source_id": "SRC-0004",
      "title": "Sun Yat-sen chronology",
      "publisher": "Museum of Dr. Sun Yat-sen (Cuiheng)",
      "url": "https://sunyat-sen.org/index.php/portal/list/index.html?id=18",
      "source_type": "biography",
      "published": null,
      "accessed": "2026-11-04",
      "rights_note": "Museum chronology in Chinese; facts used with citation in translation."
    },
    {
      "source_id": "SRC-0005",
      "title": "Liu Ruiheng",
      "publisher": "Tianjin University",
      "url": "https://en.tju.edu.cn/info/1073/1295.htm",
      "source_type": "biography",
      "published": null,
      "accessed": "2026-11-04",
      "rights_note": "University biography of the director of the Peking Union Medical College Hospital; used only for his arrival in Beijing and his admission."
    },
    {
      "source_id": "SRC-0006",
      "title": "HISTMED Master Roster v3",
      "publisher": "The Human Record project",
      "url": "https://humanrecord.example.org/internal/HISTMED_Master_Roster_v3.xlsx",
      "source_type": "other",
      "published": "2026-11-04",
      "accessed": "2026-11-04",
      "rights_note": "Internal source locator; inherited claims remain provisional until corroborated."
    }
  ],
  "synthetic_episode": {
    "calendar_frame": "modern_shifted",
    "index_date": "2026-05-04",
    "index_age": 57,
    "date_shift_policy": "HR-DATE-SHIFT-1",
    "teaching_objective": "Primary care for a 57-year-old physician by training, now a political leader, who presents with a right upper quadrant mass and weight loss: the work-up of a solid liver mass (multiphase imaging, alpha-fetoprotein, CA 19-9 and CEA, hepatitis B and C serology, liver function with Child-Pugh and ALBI scoring, and biopsy because a mass in a non-cirrhotic liver cannot be diagnosed by imaging alone, following the AASLD 2023 guidance), the finding of a gallbladder adenocarcinoma invading the liver rather than a primary liver cancer (mirroring the historical conflict between the operative and autopsy findings), staging laparoscopy and the multidisciplinary tumor board on the NCCN biliary tract cancers guideline, first-line gemcitabine, cisplatin and durvalumab with its monitoring, hepatitis B reactivation monitoring in resolved infection, early specialist palliative care, and the care of a physician as a patient.",
    "visit_schedule": [
      {
        "encounter_id": "ENC-001",
        "date": "2026-05-04",
        "purpose": "New patient with a right upper abdominal mass, aching and weight loss: work-up of a liver mass, symptom care, and how he wants to receive results"
      },
      {
        "encounter_id": "ENC-002",
        "date": "2026-05-18",
        "purpose": "Biopsy and imaging results and medical oncology consultation; diagnosis, staging plan, and hepatitis B status"
      },
      {
        "encounter_id": "ENC-003",
        "date": "2026-06-01",
        "purpose": "Staging laparoscopy result and tumor board recommendation; first cycle of chemoimmunotherapy and specialist palliative care"
      },
      {
        "encounter_id": "ENC-004",
        "date": "2026-08-03",
        "purpose": "Before cycle 4: restaging CT, tumor marker, toxicity review, hepatitis B monitoring, and genomic profiling result"
      },
      {
        "encounter_id": "ENC-006",
        "date": "2026-09-02",
        "purpose": "Same-day sick visit for a cold during chemoimmunotherapy"
      },
      {
        "encounter_id": "ENC-007",
        "date": "2026-09-21",
        "purpose": "Periodic adult preventive visit"
      },
      {
        "encounter_id": "ENC-005",
        "date": "2026-10-26",
        "purpose": "Before cycle 8: restaging CT, toxicity review, low magnesium, and the plan for maintenance durvalumab"
      }
    ]
  },
  "clinical": {
    "problems": [
      {
        "id": "PRB-001",
        "display": "Right upper quadrant abdominal mass with weight loss: a dull ache under the right ribs and early fullness for about three months, 4 kg weight loss, and a firm, non-tender mass felt 4 cm below the right costal margin; no jaundice, fever, or itching. Ultrasound today: a 6.8 cm solid, heterogeneous mass in liver segments IV and V that cannot be separated from the gallbladder, which contains stones; the rest of the liver is smooth, with no ascites. Multiphase CT, tumor markers, hepatitis serology and medical oncology consultation arranged",
        "status": "draft",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/icd-10-cm",
            "code": "R19.01",
            "display": "Right upper quadrant abdominal swelling, mass and lump",
            "version": "FY2026",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0007"
          ],
          "synthetic_reason": "Synthetic presenting problem anchored to the documented right upper abdominal mass; superseded by the biopsy diagnosis.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        },
        "clinical_status": "resolved",
        "verification_status": "confirmed",
        "problem_placement": "active",
        "abatement_date": "2026-05-18"
      },
      {
        "id": "PRB-002",
        "display": "Adenocarcinoma of the gallbladder invading the liver: core biopsy of the liver mass shows moderately differentiated adenocarcinoma (CK7 positive, CK20 and CDX2 negative), and multiphase CT and MRI show a 7.1 cm mass arising from the gallbladder fundus and invading liver segments IVb and V, with gallstones and two enlarged nodes in the hepatoduodenal ligament; no cirrhosis; alpha-fetoprotein normal, CA 19-9 raised. Clinical T3 N1 before staging laparoscopy (AJCC 8th edition). Synthetic modern episode linked to his documented final illness, described in life as liver cancer and at autopsy as gallbladder adenocarcinoma",
        "status": "draft",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/icd-10-cm",
            "code": "C23",
            "display": "Malignant neoplasm of gallbladder",
            "version": "FY2026",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0007",
            "CLM-0008",
            "CLM-0010",
            "CLM-0011"
          ],
          "synthetic_reason": "Synthetic modern diagnosis chosen to fit the documented findings: a mass involving the liver at operation and gallbladder adenocarcinoma at autopsy.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        },
        "clinical_status": "active",
        "verification_status": "confirmed",
        "problem_placement": "both_with_link",
        "recorded_date": "2026-05-18"
      },
      {
        "id": "PRB-003",
        "display": "Resolved hepatitis B infection: hepatitis B surface antigen negative, total core antibody positive, surface antibody positive, HBV DNA undetectable; hepatitis C antibody negative. At risk of reactivation during chemotherapy and immunotherapy; monitored",
        "status": "draft",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/icd-10-cm",
            "code": "Z86.19",
            "display": "Personal history of other infectious and parasitic diseases",
            "version": "FY2026",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic serology; not a claim that he had hepatitis B in his lifetime. No fetched source mentions hepatitis.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        },
        "clinical_status": "active",
        "verification_status": "confirmed",
        "problem_placement": "active",
        "recorded_date": "2026-05-18"
      },
      {
        "id": "PRB-004",
        "display": "Peritoneal metastases from gallbladder adenocarcinoma: several 3 to 6 mm nodules on the parietal peritoneum and omentum at staging laparoscopy, biopsy positive for adenocarcinoma of the same type; stage IVB (M1), not resectable",
        "status": "draft",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/icd-10-cm",
            "code": "C78.6",
            "display": "Secondary malignant neoplasm of retroperitoneum and peritoneum",
            "version": "FY2026",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0011"
          ],
          "synthetic_reason": "Synthetic finding anchored to the peritoneal metastases reported at autopsy.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        },
        "clinical_status": "active",
        "verification_status": "confirmed",
        "problem_placement": "both_with_link",
        "recorded_date": "2026-06-01"
      },
      {
        "id": "PRB-005",
        "display": "Acute viral upper respiratory infection on day 10 of cycle 5 of chemoimmunotherapy: sore throat, runny nose and dry cough for three days, afebrile, with a neutrophil count of 1.6 x10^3/uL; rapid tests for SARS-CoV-2 and influenza negative; no sign of pneumonia or pneumonitis; resolved",
        "status": "draft",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/icd-10-cm",
            "code": "J06.9",
            "display": "Acute upper respiratory infection, unspecified",
            "version": "FY2026",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic acute illness; not a historical claim.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        },
        "clinical_status": "resolved",
        "verification_status": "confirmed",
        "problem_placement": "active",
        "recorded_date": "2026-09-02",
        "abatement_date": "2026-09-21"
      }
    ],
    "medications": [
      {
        "id": "MED-001",
        "display": "Acetaminophen 500 mg oral tablet, two tablets by mouth every 8 hours as needed for right upper abdominal ache; no more than 3,000 mg a day",
        "status": "active",
        "coding": [
          {
            "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
            "code": "198440",
            "display": "acetaminophen 500 MG Oral Tablet",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "dose": {
          "value": 2,
          "unit": "1"
        },
        "route": "oral",
        "frequency": {
          "period": 8,
          "period_unit": "h",
          "text": "Two tablets by mouth every 8 hours as needed, no more than 3,000 mg a day"
        },
        "start_date": "2026-05-04",
        "indication_problem_ids": [
          "PRB-001"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic first-line analgesic; the dose ceiling allows for the liver mass.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "MED-002",
        "display": "Gemcitabine 1,000 mg/m2 (1,660 mg) intravenous infusion on days 1 and 8 of each 21-day cycle",
        "status": "active",
        "coding": [
          {
            "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
            "code": "1719003",
            "display": "gemcitabine 1000 MG Injection",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "dose": {
          "value": 1660,
          "unit": "mg"
        },
        "route": "intravenous",
        "frequency": {
          "period": 21,
          "period_unit": "d",
          "text": "Days 1 and 8 of each 21-day cycle, up to 8 cycles"
        },
        "start_date": "2026-06-01",
        "indication_problem_ids": [
          "PRB-002",
          "PRB-004"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0007",
            "CLM-0008",
            "CLM-0010",
            "CLM-0011"
          ],
          "synthetic_reason": "Synthetic first-line chemoimmunotherapy for stage IVB gallbladder adenocarcinoma, decided after the staging laparoscopy.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "MED-003",
        "display": "Cisplatin 25 mg/m2 (41 mg) intravenous infusion on days 1 and 8 of each 21-day cycle",
        "status": "active",
        "coding": [
          {
            "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
            "code": "309311",
            "display": "cisplatin 1 MG/ML Injectable Solution",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "dose": {
          "value": 41,
          "unit": "mg"
        },
        "route": "intravenous",
        "frequency": {
          "period": 21,
          "period_unit": "d",
          "text": "Days 1 and 8 of each 21-day cycle, up to 8 cycles, with hydration"
        },
        "start_date": "2026-06-01",
        "indication_problem_ids": [
          "PRB-002",
          "PRB-004"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0007",
            "CLM-0008",
            "CLM-0010",
            "CLM-0011"
          ],
          "synthetic_reason": "Synthetic first-line chemoimmunotherapy for stage IVB gallbladder adenocarcinoma, decided after the staging laparoscopy.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "MED-004",
        "display": "Durvalumab 1,500 mg intravenous infusion on day 1 of each 21-day cycle",
        "status": "active",
        "coding": [
          {
            "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
            "code": "1919515",
            "display": "10 ML durvalumab 50 MG/ML Injection",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "dose": {
          "value": 1500,
          "unit": "mg"
        },
        "route": "intravenous",
        "frequency": {
          "period": 21,
          "period_unit": "d",
          "text": "Day 1 of each 21-day cycle with chemotherapy, then every 4 weeks alone"
        },
        "start_date": "2026-06-01",
        "indication_problem_ids": [
          "PRB-002",
          "PRB-004"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0007",
            "CLM-0008",
            "CLM-0010",
            "CLM-0011"
          ],
          "synthetic_reason": "Synthetic first-line chemoimmunotherapy for stage IVB gallbladder adenocarcinoma, decided after the staging laparoscopy.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "MED-005",
        "display": "Ondansetron 8 mg oral tablet, one tablet by mouth every 8 hours as needed for nausea",
        "status": "active",
        "coding": [
          {
            "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
            "code": "312086",
            "display": "ondansetron 8 MG Oral Tablet",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "dose": {
          "value": 1,
          "unit": "1"
        },
        "route": "oral",
        "frequency": {
          "period": 8,
          "period_unit": "h",
          "text": "One tablet by mouth every 8 hours as needed for nausea"
        },
        "start_date": "2026-06-01",
        "indication_problem_ids": [
          "PRB-002"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic home antiemetic after the infusion-center antiemetic protocol.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "MED-006",
        "display": "Magnesium oxide 400 mg oral tablet, one tablet by mouth daily",
        "status": "active",
        "coding": [
          {
            "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
            "code": "198741",
            "display": "magnesium oxide 400 MG Oral Tablet",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "dose": {
          "value": 1,
          "unit": "1"
        },
        "route": "oral",
        "frequency": {
          "period": 1,
          "period_unit": "d",
          "text": "One tablet by mouth daily"
        },
        "start_date": "2026-10-26",
        "indication_problem_ids": [
          "PRB-002"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic magnesium replacement for cisplatin-related low magnesium.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      }
    ],
    "allergies": [
      {
        "id": "ALG-001",
        "display": "No known allergy",
        "status": "active",
        "assertion": "no_known_allergy",
        "substance": {
          "system": "http://snomed.info/sct",
          "code": "716186003",
          "display": "No known allergy"
        },
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic allergy assertion for EHR completeness; not a historical assertion.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      }
    ],
    "observations": [
      {
        "id": "OBS-WBC-V1",
        "display": "Leukocytes [#/volume] in Blood by Automated count",
        "label": "White cells",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-05-04",
        "value": 7.9,
        "unit": "10*3/uL",
        "reference_range": {
          "low": 4.0,
          "high": 11.0
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "6690-2",
            "display": "Leukocytes [#/volume] in Blood by Automated count",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic blood count at intake; mild anemia.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "OBS-HGB-V1",
        "display": "Hemoglobin [Mass/volume] in Blood",
        "label": "Hemoglobin",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-05-04",
        "value": 12.6,
        "unit": "g/dL",
        "reference_range": {
          "low": 13.2,
          "high": 17.1
        },
        "interpretation": "L",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "718-7",
            "display": "Hemoglobin [Mass/volume] in Blood",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic blood count at intake; mild anemia.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "OBS-PLT-V1",
        "display": "Platelets [#/volume] in Blood by Automated count",
        "label": "Platelets",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-05-04",
        "value": 342,
        "unit": "10*3/uL",
        "reference_range": {
          "low": 150,
          "high": 400
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "777-3",
            "display": "Platelets [#/volume] in Blood by Automated count",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic blood count at intake; mild anemia.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "OBS-NA-V1",
        "display": "Sodium [Moles/volume] in Serum or Plasma",
        "label": "Sodium",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-05-04",
        "value": 137,
        "unit": "mmol/L",
        "reference_range": {
          "low": 135,
          "high": 145
        },
        "interpretation": "N",
        "panel": {
          "code": "51990-0",
          "display": "Basic metabolic panel - Blood"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2951-2",
            "display": "Sodium [Moles/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic metabolic panel at intake.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "OBS-K-V1",
        "display": "Potassium [Moles/volume] in Serum or Plasma",
        "label": "Potassium",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-05-04",
        "value": 4.2,
        "unit": "mmol/L",
        "reference_range": {
          "low": 3.5,
          "high": 5.1
        },
        "interpretation": "N",
        "panel": {
          "code": "51990-0",
          "display": "Basic metabolic panel - Blood"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2823-3",
            "display": "Potassium [Moles/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic metabolic panel at intake.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "OBS-CR-V1",
        "display": "Creatinine [Mass/volume] in Serum or Plasma",
        "label": "Creatinine",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-05-04",
        "value": 0.86,
        "unit": "mg/dL",
        "reference_range": {
          "low": 0.74,
          "high": 1.35
        },
        "interpretation": "N",
        "panel": {
          "code": "51990-0",
          "display": "Basic metabolic panel - Blood"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2160-0",
            "display": "Creatinine [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic metabolic panel at intake.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "OBS-EGFR-V1",
        "display": "Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M",
        "label": "eGFR",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-05-04",
        "value": 101,
        "unit": "mL/min/{1.73_m2}",
        "reference_range": {
          "low": 60
        },
        "interpretation": "N",
        "panel": {
          "code": "51990-0",
          "display": "Basic metabolic panel - Blood"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "98979-8",
            "display": "Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic metabolic panel at intake.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "OBS-GLU-V1",
        "display": "Glucose [Mass/volume] in Serum or Plasma",
        "label": "Glucose",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-05-04",
        "value": 98,
        "unit": "mg/dL",
        "reference_range": {
          "low": 70,
          "high": 99
        },
        "interpretation": "N",
        "panel": {
          "code": "51990-0",
          "display": "Basic metabolic panel - Blood"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2345-7",
            "display": "Glucose [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic metabolic panel at intake.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "OBS-ALB-V1",
        "display": "Albumin [Mass/volume] in Serum or Plasma",
        "label": "Albumin",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-05-04",
        "value": 3.4,
        "unit": "g/dL",
        "reference_range": {
          "low": 3.5,
          "high": 5.0
        },
        "interpretation": "L",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "1751-7",
            "display": "Albumin [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic liver tests at intake: raised alkaline phosphatase without jaundice, consistent with the documented absence of jaundice.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "OBS-TBIL-V1",
        "display": "Bilirubin.total [Mass/volume] in Serum or Plasma",
        "label": "Total bilirubin",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-05-04",
        "value": 0.9,
        "unit": "mg/dL",
        "reference_range": {
          "low": 0.2,
          "high": 1.2
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "1975-2",
            "display": "Bilirubin.total [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic liver tests at intake: raised alkaline phosphatase without jaundice, consistent with the documented absence of jaundice.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "OBS-ALP-V1",
        "display": "Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma",
        "label": "Alkaline phosphatase",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-05-04",
        "value": 212,
        "unit": "U/L",
        "reference_range": {
          "low": 40,
          "high": 129
        },
        "interpretation": "H",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "6768-6",
            "display": "Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic liver tests at intake: raised alkaline phosphatase without jaundice, consistent with the documented absence of jaundice.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "OBS-AST-V1",
        "display": "Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
        "label": "AST",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-05-04",
        "value": 48,
        "unit": "U/L",
        "reference_range": {
          "low": 10,
          "high": 40
        },
        "interpretation": "H",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "1920-8",
            "display": "Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic liver tests at intake: raised alkaline phosphatase without jaundice, consistent with the documented absence of jaundice.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "OBS-ALT-V1",
        "display": "Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
        "label": "ALT",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-05-04",
        "value": 41,
        "unit": "U/L",
        "reference_range": {
          "low": 7,
          "high": 55
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "1742-6",
            "display": "Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic liver tests at intake: raised alkaline phosphatase without jaundice, consistent with the documented absence of jaundice.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "OBS-INR-V1",
        "display": "INR in Platelet poor plasma by Coagulation assay",
        "label": "INR",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-05-04",
        "value": 1.0,
        "unit": "{INR}",
        "reference_range": {
          "low": 0.9,
          "high": 1.1
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "6301-6",
            "display": "INR in Platelet poor plasma by Coagulation assay",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic INR at intake.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "OBS-AFP-V1",
        "display": "Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma",
        "label": "Alpha-fetoprotein",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-05-04",
        "value": 3.2,
        "unit": "ng/mL",
        "reference_range": {
          "high": 8.3
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "1834-1",
            "display": "Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic alpha-fetoprotein at intake; normal.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "OBS-CA199-V1",
        "display": "Cancer Ag 19-9 [Units/volume] in Serum or Plasma",
        "label": "CA 19-9",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-05-04",
        "value": 412,
        "unit": "U/mL",
        "reference_range": {
          "high": 35
        },
        "interpretation": "H",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "24108-3",
            "display": "Cancer Ag 19-9 [Units/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic CA 19-9 at intake; raised.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "OBS-CEA-V1",
        "display": "Carcinoembryonic Ag [Mass/volume] in Serum or Plasma",
        "label": "CEA",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-05-04",
        "value": 8.6,
        "unit": "ng/mL",
        "reference_range": {
          "high": 3.0,
          "text": "Up to 3.0 ng/mL in non-smokers"
        },
        "interpretation": "H",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2039-6",
            "display": "Carcinoembryonic Ag [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic CEA at intake; raised.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "OBS-PHQ2-V1",
        "display": "Patient Health Questionnaire 2 item (PHQ-2) total score [Reported]",
        "label": "PHQ-2",
        "status": "final",
        "effective_date": "2026-05-04",
        "value": 1,
        "unit": "{score}",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "55758-7",
            "display": "Patient Health Questionnaire 2 item (PHQ-2) total score [Reported]",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic depression screen at intake; negative.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "OBS-ECOG-V1",
        "display": "ECOG Performance Status score",
        "label": "ECOG performance status",
        "status": "final",
        "effective_date": "2026-05-04",
        "value": 1,
        "unit": "{score}",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "89247-1",
            "display": "ECOG Performance Status score",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic performance status at intake.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "OBS-ECOG-V2",
        "display": "ECOG Performance Status score",
        "label": "ECOG performance status",
        "status": "final",
        "effective_date": "2026-05-18",
        "value": 1,
        "unit": "{score}",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "89247-1",
            "display": "ECOG Performance Status score",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic performance status at the consultation.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "OBS-WBC-V3",
        "display": "Leukocytes [#/volume] in Blood by Automated count",
        "label": "White cells",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-06-01",
        "value": 7.4,
        "unit": "10*3/uL",
        "reference_range": {
          "low": 4.0,
          "high": 11.0
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "6690-2",
            "display": "Leukocytes [#/volume] in Blood by Automated count",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic blood count before cycle 1.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "OBS-ANC-V3",
        "display": "Neutrophils [#/volume] in Blood by Automated count",
        "label": "Neutrophils",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-06-01",
        "value": 4.9,
        "unit": "10*3/uL",
        "reference_range": {
          "low": 1.8,
          "high": 7.7
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "751-8",
            "display": "Neutrophils [#/volume] in Blood by Automated count",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic blood count before cycle 1.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "OBS-HGB-V3",
        "display": "Hemoglobin [Mass/volume] in Blood",
        "label": "Hemoglobin",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-06-01",
        "value": 12.2,
        "unit": "g/dL",
        "reference_range": {
          "low": 13.2,
          "high": 17.1
        },
        "interpretation": "L",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "718-7",
            "display": "Hemoglobin [Mass/volume] in Blood",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic blood count before cycle 1.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "OBS-PLT-V3",
        "display": "Platelets [#/volume] in Blood by Automated count",
        "label": "Platelets",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-06-01",
        "value": 318,
        "unit": "10*3/uL",
        "reference_range": {
          "low": 150,
          "high": 400
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "777-3",
            "display": "Platelets [#/volume] in Blood by Automated count",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic blood count before cycle 1.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "OBS-NA-V3",
        "display": "Sodium [Moles/volume] in Serum or Plasma",
        "label": "Sodium",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-06-01",
        "value": 137,
        "unit": "mmol/L",
        "reference_range": {
          "low": 135,
          "high": 145
        },
        "interpretation": "N",
        "panel": {
          "code": "51990-0",
          "display": "Basic metabolic panel - Blood"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2951-2",
            "display": "Sodium [Moles/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic metabolic panel before cycle 1.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "OBS-K-V3",
        "display": "Potassium [Moles/volume] in Serum or Plasma",
        "label": "Potassium",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-06-01",
        "value": 4.3,
        "unit": "mmol/L",
        "reference_range": {
          "low": 3.5,
          "high": 5.1
        },
        "interpretation": "N",
        "panel": {
          "code": "51990-0",
          "display": "Basic metabolic panel - Blood"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2823-3",
            "display": "Potassium [Moles/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic metabolic panel before cycle 1.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "OBS-CR-V3",
        "display": "Creatinine [Mass/volume] in Serum or Plasma",
        "label": "Creatinine",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-06-01",
        "value": 0.84,
        "unit": "mg/dL",
        "reference_range": {
          "low": 0.74,
          "high": 1.35
        },
        "interpretation": "N",
        "panel": {
          "code": "51990-0",
          "display": "Basic metabolic panel - Blood"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2160-0",
            "display": "Creatinine [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic metabolic panel before cycle 1.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "OBS-EGFR-V3",
        "display": "Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M",
        "label": "eGFR",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-06-01",
        "value": 102,
        "unit": "mL/min/{1.73_m2}",
        "reference_range": {
          "low": 60
        },
        "interpretation": "N",
        "panel": {
          "code": "51990-0",
          "display": "Basic metabolic panel - Blood"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "98979-8",
            "display": "Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic metabolic panel before cycle 1.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "OBS-MG-V3",
        "display": "Magnesium [Mass/volume] in Serum or Plasma",
        "label": "Magnesium",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-06-01",
        "value": 2.0,
        "unit": "mg/dL",
        "reference_range": {
          "low": 1.7,
          "high": 2.2
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "19123-9",
            "display": "Magnesium [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic magnesium, checked before each cisplatin dose.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "OBS-ALB-V3",
        "display": "Albumin [Mass/volume] in Serum or Plasma",
        "label": "Albumin",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-06-01",
        "value": 3.4,
        "unit": "g/dL",
        "reference_range": {
          "low": 3.5,
          "high": 5.0
        },
        "interpretation": "L",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "1751-7",
            "display": "Albumin [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic liver tests before cycle 1.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "OBS-TBIL-V3",
        "display": "Bilirubin.total [Mass/volume] in Serum or Plasma",
        "label": "Total bilirubin",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-06-01",
        "value": 0.8,
        "unit": "mg/dL",
        "reference_range": {
          "low": 0.2,
          "high": 1.2
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "1975-2",
            "display": "Bilirubin.total [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic liver tests before cycle 1.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "OBS-ALP-V3",
        "display": "Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma",
        "label": "Alkaline phosphatase",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-06-01",
        "value": 236,
        "unit": "U/L",
        "reference_range": {
          "low": 40,
          "high": 129
        },
        "interpretation": "H",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "6768-6",
            "display": "Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic liver tests before cycle 1.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "OBS-AST-V3",
        "display": "Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
        "label": "AST",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-06-01",
        "value": 52,
        "unit": "U/L",
        "reference_range": {
          "low": 10,
          "high": 40
        },
        "interpretation": "H",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "1920-8",
            "display": "Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic liver tests before cycle 1.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "OBS-ALT-V3",
        "display": "Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
        "label": "ALT",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-06-01",
        "value": 44,
        "unit": "U/L",
        "reference_range": {
          "low": 7,
          "high": 55
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "1742-6",
            "display": "Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic liver tests before cycle 1.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "OBS-TSH-V3",
        "display": "Thyrotropin [Units/volume] in Serum or Plasma",
        "label": "TSH",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-06-01",
        "value": 1.9,
        "unit": "m[IU]/L",
        "reference_range": {
          "low": 0.45,
          "high": 4.5
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "3016-3",
            "display": "Thyrotropin [Units/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic baseline TSH before durvalumab.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "OBS-CA199-V3",
        "display": "Cancer Ag 19-9 [Units/volume] in Serum or Plasma",
        "label": "CA 19-9",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-06-01",
        "value": 498,
        "unit": "U/mL",
        "reference_range": {
          "high": 35
        },
        "interpretation": "H",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "24108-3",
            "display": "Cancer Ag 19-9 [Units/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic baseline CA 19-9 before treatment.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "OBS-PHQ9-V3",
        "display": "Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]",
        "label": "PHQ-9",
        "status": "final",
        "effective_date": "2026-06-01",
        "value": 6,
        "unit": "{score}",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "44261-6",
            "display": "Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic PHQ-9 after learning of advanced cancer; mild symptoms, no thoughts of self-harm.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "OBS-ECOG-V3",
        "display": "ECOG Performance Status score",
        "label": "ECOG performance status",
        "status": "final",
        "effective_date": "2026-06-01",
        "value": 1,
        "unit": "{score}",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "89247-1",
            "display": "ECOG Performance Status score",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic performance status before cycle 1.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "OBS-WBC-V4",
        "display": "Leukocytes [#/volume] in Blood by Automated count",
        "label": "White cells",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-08-03",
        "value": 4.6,
        "unit": "10*3/uL",
        "reference_range": {
          "low": 4.0,
          "high": 11.0
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "6690-2",
            "display": "Leukocytes [#/volume] in Blood by Automated count",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic blood count before cycle 4.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "OBS-ANC-V4",
        "display": "Neutrophils [#/volume] in Blood by Automated count",
        "label": "Neutrophils",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-08-03",
        "value": 2.4,
        "unit": "10*3/uL",
        "reference_range": {
          "low": 1.8,
          "high": 7.7
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "751-8",
            "display": "Neutrophils [#/volume] in Blood by Automated count",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic blood count before cycle 4.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "OBS-HGB-V4",
        "display": "Hemoglobin [Mass/volume] in Blood",
        "label": "Hemoglobin",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-08-03",
        "value": 10.9,
        "unit": "g/dL",
        "reference_range": {
          "low": 13.2,
          "high": 17.1
        },
        "interpretation": "L",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "718-7",
            "display": "Hemoglobin [Mass/volume] in Blood",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic blood count before cycle 4.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "OBS-PLT-V4",
        "display": "Platelets [#/volume] in Blood by Automated count",
        "label": "Platelets",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-08-03",
        "value": 188,
        "unit": "10*3/uL",
        "reference_range": {
          "low": 150,
          "high": 400
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "777-3",
            "display": "Platelets [#/volume] in Blood by Automated count",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic blood count before cycle 4.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "OBS-NA-V4",
        "display": "Sodium [Moles/volume] in Serum or Plasma",
        "label": "Sodium",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-08-03",
        "value": 136,
        "unit": "mmol/L",
        "reference_range": {
          "low": 135,
          "high": 145
        },
        "interpretation": "N",
        "panel": {
          "code": "51990-0",
          "display": "Basic metabolic panel - Blood"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2951-2",
            "display": "Sodium [Moles/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic metabolic panel before cycle 4.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "OBS-K-V4",
        "display": "Potassium [Moles/volume] in Serum or Plasma",
        "label": "Potassium",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-08-03",
        "value": 4.0,
        "unit": "mmol/L",
        "reference_range": {
          "low": 3.5,
          "high": 5.1
        },
        "interpretation": "N",
        "panel": {
          "code": "51990-0",
          "display": "Basic metabolic panel - Blood"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2823-3",
            "display": "Potassium [Moles/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic metabolic panel before cycle 4.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "OBS-CR-V4",
        "display": "Creatinine [Mass/volume] in Serum or Plasma",
        "label": "Creatinine",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-08-03",
        "value": 0.92,
        "unit": "mg/dL",
        "reference_range": {
          "low": 0.74,
          "high": 1.35
        },
        "interpretation": "N",
        "panel": {
          "code": "51990-0",
          "display": "Basic metabolic panel - Blood"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2160-0",
            "display": "Creatinine [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic metabolic panel before cycle 4.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "OBS-EGFR-V4",
        "display": "Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M",
        "label": "eGFR",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-08-03",
        "value": 97,
        "unit": "mL/min/{1.73_m2}",
        "reference_range": {
          "low": 60
        },
        "interpretation": "N",
        "panel": {
          "code": "51990-0",
          "display": "Basic metabolic panel - Blood"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "98979-8",
            "display": "Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic metabolic panel before cycle 4.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "OBS-GLU-V4",
        "display": "Glucose [Mass/volume] in Serum or Plasma",
        "label": "Glucose",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-08-03",
        "value": 94,
        "unit": "mg/dL",
        "reference_range": {
          "low": 70,
          "high": 99
        },
        "interpretation": "N",
        "panel": {
          "code": "51990-0",
          "display": "Basic metabolic panel - Blood"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2345-7",
            "display": "Glucose [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic metabolic panel before cycle 4.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "OBS-MG-V4",
        "display": "Magnesium [Mass/volume] in Serum or Plasma",
        "label": "Magnesium",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-08-03",
        "value": 1.7,
        "unit": "mg/dL",
        "reference_range": {
          "low": 1.7,
          "high": 2.2
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "19123-9",
            "display": "Magnesium [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic magnesium, checked before each cisplatin dose.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "OBS-ALB-V4",
        "display": "Albumin [Mass/volume] in Serum or Plasma",
        "label": "Albumin",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-08-03",
        "value": 3.6,
        "unit": "g/dL",
        "reference_range": {
          "low": 3.5,
          "high": 5.0
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "1751-7",
            "display": "Albumin [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic liver tests before cycle 4.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "OBS-TBIL-V4",
        "display": "Bilirubin.total [Mass/volume] in Serum or Plasma",
        "label": "Total bilirubin",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-08-03",
        "value": 0.7,
        "unit": "mg/dL",
        "reference_range": {
          "low": 0.2,
          "high": 1.2
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "1975-2",
            "display": "Bilirubin.total [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic liver tests before cycle 4.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "OBS-ALP-V4",
        "display": "Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma",
        "label": "Alkaline phosphatase",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-08-03",
        "value": 158,
        "unit": "U/L",
        "reference_range": {
          "low": 40,
          "high": 129
        },
        "interpretation": "H",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "6768-6",
            "display": "Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic liver tests before cycle 4.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "OBS-AST-V4",
        "display": "Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
        "label": "AST",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-08-03",
        "value": 34,
        "unit": "U/L",
        "reference_range": {
          "low": 10,
          "high": 40
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "1920-8",
            "display": "Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic liver tests before cycle 4.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "OBS-ALT-V4",
        "display": "Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
        "label": "ALT",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-08-03",
        "value": 30,
        "unit": "U/L",
        "reference_range": {
          "low": 7,
          "high": 55
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "1742-6",
            "display": "Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic liver tests before cycle 4.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "OBS-TSH-V4",
        "display": "Thyrotropin [Units/volume] in Serum or Plasma",
        "label": "TSH",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-08-03",
        "value": 2.4,
        "unit": "m[IU]/L",
        "reference_range": {
          "low": 0.45,
          "high": 4.5
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "3016-3",
            "display": "Thyrotropin [Units/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic TSH on durvalumab.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "OBS-CA199-V4",
        "display": "Cancer Ag 19-9 [Units/volume] in Serum or Plasma",
        "label": "CA 19-9",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-08-03",
        "value": 168,
        "unit": "U/mL",
        "reference_range": {
          "high": 35
        },
        "interpretation": "H",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "24108-3",
            "display": "Cancer Ag 19-9 [Units/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic CA 19-9 after three cycles; falling.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "OBS-PHQ9-V4",
        "display": "Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]",
        "label": "PHQ-9",
        "status": "final",
        "effective_date": "2026-08-03",
        "value": 5,
        "unit": "{score}",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "44261-6",
            "display": "Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic PHQ-9 on treatment.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "OBS-ECOG-V4",
        "display": "ECOG Performance Status score",
        "label": "ECOG performance status",
        "status": "final",
        "effective_date": "2026-08-03",
        "value": 1,
        "unit": "{score}",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "89247-1",
            "display": "ECOG Performance Status score",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic performance status before cycle 4.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "OBS-WBC-V5",
        "display": "Leukocytes [#/volume] in Blood by Automated count",
        "label": "White cells",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-10-26",
        "value": 4.3,
        "unit": "10*3/uL",
        "reference_range": {
          "low": 4.0,
          "high": 11.0
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "6690-2",
            "display": "Leukocytes [#/volume] in Blood by Automated count",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic blood count before cycle 8.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "OBS-ANC-V5",
        "display": "Neutrophils [#/volume] in Blood by Automated count",
        "label": "Neutrophils",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-10-26",
        "value": 2.1,
        "unit": "10*3/uL",
        "reference_range": {
          "low": 1.8,
          "high": 7.7
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "751-8",
            "display": "Neutrophils [#/volume] in Blood by Automated count",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic blood count before cycle 8.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "OBS-HGB-V5",
        "display": "Hemoglobin [Mass/volume] in Blood",
        "label": "Hemoglobin",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-10-26",
        "value": 10.7,
        "unit": "g/dL",
        "reference_range": {
          "low": 13.2,
          "high": 17.1
        },
        "interpretation": "L",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "718-7",
            "display": "Hemoglobin [Mass/volume] in Blood",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic blood count before cycle 8.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "OBS-PLT-V5",
        "display": "Platelets [#/volume] in Blood by Automated count",
        "label": "Platelets",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-10-26",
        "value": 176,
        "unit": "10*3/uL",
        "reference_range": {
          "low": 150,
          "high": 400
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "777-3",
            "display": "Platelets [#/volume] in Blood by Automated count",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic blood count before cycle 8.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "OBS-NA-V5",
        "display": "Sodium [Moles/volume] in Serum or Plasma",
        "label": "Sodium",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-10-26",
        "value": 137,
        "unit": "mmol/L",
        "reference_range": {
          "low": 135,
          "high": 145
        },
        "interpretation": "N",
        "panel": {
          "code": "51990-0",
          "display": "Basic metabolic panel - Blood"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2951-2",
            "display": "Sodium [Moles/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic metabolic panel before cycle 8; low magnesium on cisplatin.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "OBS-K-V5",
        "display": "Potassium [Moles/volume] in Serum or Plasma",
        "label": "Potassium",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-10-26",
        "value": 4.1,
        "unit": "mmol/L",
        "reference_range": {
          "low": 3.5,
          "high": 5.1
        },
        "interpretation": "N",
        "panel": {
          "code": "51990-0",
          "display": "Basic metabolic panel - Blood"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2823-3",
            "display": "Potassium [Moles/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic metabolic panel before cycle 8; low magnesium on cisplatin.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "OBS-CR-V5",
        "display": "Creatinine [Mass/volume] in Serum or Plasma",
        "label": "Creatinine",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-10-26",
        "value": 0.95,
        "unit": "mg/dL",
        "reference_range": {
          "low": 0.74,
          "high": 1.35
        },
        "interpretation": "N",
        "panel": {
          "code": "51990-0",
          "display": "Basic metabolic panel - Blood"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2160-0",
            "display": "Creatinine [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic metabolic panel before cycle 8; low magnesium on cisplatin.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "OBS-EGFR-V5",
        "display": "Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M",
        "label": "eGFR",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-10-26",
        "value": 93,
        "unit": "mL/min/{1.73_m2}",
        "reference_range": {
          "low": 60
        },
        "interpretation": "N",
        "panel": {
          "code": "51990-0",
          "display": "Basic metabolic panel - Blood"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "98979-8",
            "display": "Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic metabolic panel before cycle 8; low magnesium on cisplatin.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "OBS-GLU-V5",
        "display": "Glucose [Mass/volume] in Serum or Plasma",
        "label": "Glucose",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-10-26",
        "value": 96,
        "unit": "mg/dL",
        "reference_range": {
          "low": 70,
          "high": 99
        },
        "interpretation": "N",
        "panel": {
          "code": "51990-0",
          "display": "Basic metabolic panel - Blood"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2345-7",
            "display": "Glucose [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic metabolic panel before cycle 8; low magnesium on cisplatin.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "OBS-MG-V5",
        "display": "Magnesium [Mass/volume] in Serum or Plasma",
        "label": "Magnesium",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-10-26",
        "value": 1.6,
        "unit": "mg/dL",
        "reference_range": {
          "low": 1.7,
          "high": 2.2
        },
        "interpretation": "L",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "19123-9",
            "display": "Magnesium [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic magnesium, checked before each cisplatin dose.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "OBS-ALB-V5",
        "display": "Albumin [Mass/volume] in Serum or Plasma",
        "label": "Albumin",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-10-26",
        "value": 3.7,
        "unit": "g/dL",
        "reference_range": {
          "low": 3.5,
          "high": 5.0
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "1751-7",
            "display": "Albumin [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic liver tests before cycle 8.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "OBS-TBIL-V5",
        "display": "Bilirubin.total [Mass/volume] in Serum or Plasma",
        "label": "Total bilirubin",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-10-26",
        "value": 0.6,
        "unit": "mg/dL",
        "reference_range": {
          "low": 0.2,
          "high": 1.2
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "1975-2",
            "display": "Bilirubin.total [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic liver tests before cycle 8.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "OBS-ALP-V5",
        "display": "Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma",
        "label": "Alkaline phosphatase",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-10-26",
        "value": 141,
        "unit": "U/L",
        "reference_range": {
          "low": 40,
          "high": 129
        },
        "interpretation": "H",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "6768-6",
            "display": "Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic liver tests before cycle 8.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "OBS-AST-V5",
        "display": "Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
        "label": "AST",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-10-26",
        "value": 31,
        "unit": "U/L",
        "reference_range": {
          "low": 10,
          "high": 40
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "1920-8",
            "display": "Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic liver tests before cycle 8.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "OBS-ALT-V5",
        "display": "Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
        "label": "ALT",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-10-26",
        "value": 28,
        "unit": "U/L",
        "reference_range": {
          "low": 7,
          "high": 55
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "1742-6",
            "display": "Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic liver tests before cycle 8.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "OBS-TSH-V5",
        "display": "Thyrotropin [Units/volume] in Serum or Plasma",
        "label": "TSH",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-10-26",
        "value": 3.1,
        "unit": "m[IU]/L",
        "reference_range": {
          "low": 0.45,
          "high": 4.5
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "3016-3",
            "display": "Thyrotropin [Units/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic TSH on durvalumab.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "OBS-CA199-V5",
        "display": "Cancer Ag 19-9 [Units/volume] in Serum or Plasma",
        "label": "CA 19-9",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-10-26",
        "value": 121,
        "unit": "U/mL",
        "reference_range": {
          "high": 35
        },
        "interpretation": "H",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "24108-3",
            "display": "Cancer Ag 19-9 [Units/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic CA 19-9 after seven cycles.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "OBS-PHQ9-V5",
        "display": "Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]",
        "label": "PHQ-9",
        "status": "final",
        "effective_date": "2026-10-26",
        "value": 4,
        "unit": "{score}",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "44261-6",
            "display": "Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic PHQ-9 on treatment.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "OBS-ECOG-V5",
        "display": "ECOG Performance Status score",
        "label": "ECOG performance status",
        "status": "final",
        "effective_date": "2026-10-26",
        "value": 1,
        "unit": "{score}",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "89247-1",
            "display": "ECOG Performance Status score",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic performance status before cycle 8.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "OBS-WBC-V6",
        "display": "Leukocytes [#/volume] in Blood by Automated count",
        "label": "White cells",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-09-02",
        "value": 3.9,
        "unit": "10*3/uL",
        "reference_range": {
          "low": 4.0,
          "high": 11.0
        },
        "interpretation": "L",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "6690-2",
            "display": "Leukocytes [#/volume] in Blood by Automated count",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic blood count at the sick visit, two days after a day-8 dose.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "OBS-ANC-V6",
        "display": "Neutrophils [#/volume] in Blood by Automated count",
        "label": "Neutrophils",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-09-02",
        "value": 1.6,
        "unit": "10*3/uL",
        "reference_range": {
          "low": 1.8,
          "high": 7.7
        },
        "interpretation": "L",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "751-8",
            "display": "Neutrophils [#/volume] in Blood by Automated count",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic neutrophil count at the sick visit; mild neutropenia.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "OBS-HGB-V6",
        "display": "Hemoglobin [Mass/volume] in Blood",
        "label": "Hemoglobin",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-09-02",
        "value": 10.6,
        "unit": "g/dL",
        "reference_range": {
          "low": 13.2,
          "high": 17.1
        },
        "interpretation": "L",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "718-7",
            "display": "Hemoglobin [Mass/volume] in Blood",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic hemoglobin at the sick visit.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "OBS-PLT-V6",
        "display": "Platelets [#/volume] in Blood by Automated count",
        "label": "Platelets",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-09-02",
        "value": 162,
        "unit": "10*3/uL",
        "reference_range": {
          "low": 150,
          "high": 400
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "777-3",
            "display": "Platelets [#/volume] in Blood by Automated count",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic platelets at the sick visit.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "OBS-PHQ2-V7",
        "display": "Patient Health Questionnaire 2 item (PHQ-2) total score [Reported]",
        "label": "PHQ-2",
        "status": "final",
        "effective_date": "2026-09-21",
        "value": 1,
        "unit": "{score}",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "55758-7",
            "display": "Patient Health Questionnaire 2 item (PHQ-2) total score [Reported]",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic depression screen at the preventive visit; negative.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      }
    ],
    "procedures": [
      {
        "id": "PROC-001",
        "display": "Ultrasound of the abdomen",
        "status": "completed",
        "coding": [
          {
            "system": "http://snomed.info/sct",
            "code": "45036003",
            "display": "Ultrasonography of abdomen",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "period": {
          "start": "2026-05-04",
          "end": "2026-05-04"
        },
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0007"
          ],
          "synthetic_reason": "Synthetic first imaging of the palpable mass.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "PROC-002",
        "display": "Multiphase contrast CT of the liver with CT of the chest, abdomen and pelvis",
        "status": "completed",
        "coding": [
          {
            "system": "http://snomed.info/sct",
            "code": "429864007",
            "display": "CT of thorax and abdomen with contrast",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "period": {
          "start": "2026-05-07",
          "end": "2026-05-07"
        },
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic staging imaging ordered at intake.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "PROC-003",
        "display": "MRI of the liver with MRCP",
        "status": "completed",
        "coding": [
          {
            "system": "http://snomed.info/sct",
            "code": "314635004",
            "display": "Magnetic resonance cholangiopancreatography",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "period": {
          "start": "2026-05-11",
          "end": "2026-05-11"
        },
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic imaging to define the origin of the mass.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "PROC-004",
        "display": "Ultrasound-guided core biopsy of the liver mass",
        "status": "completed",
        "coding": [
          {
            "system": "http://snomed.info/sct",
            "code": "438300009",
            "display": "Biopsy of liver using ultrasound guidance",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "period": {
          "start": "2026-05-13",
          "end": "2026-05-13"
        },
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0007",
            "CLM-0008",
            "CLM-0010",
            "CLM-0011"
          ],
          "synthetic_reason": "Synthetic diagnostic biopsy; a mass in a non-cirrhotic liver needs tissue.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "PROC-005",
        "display": "Multidisciplinary hepatobiliary tumor board review before staging",
        "status": "completed",
        "coding": [
          {
            "system": "http://snomed.info/sct",
            "code": "384682003",
            "display": "Multidisciplinary care conference",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "period": {
          "start": "2026-05-20",
          "end": "2026-05-20"
        },
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic tumor board.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "PROC-006",
        "display": "Staging laparoscopy",
        "status": "completed",
        "coding": [
          {
            "system": "http://snomed.info/sct",
            "code": "73632009",
            "display": "Laparoscopy",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "period": {
          "start": "2026-05-27",
          "end": "2026-05-27"
        },
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0007",
            "CLM-0008",
            "CLM-0010",
            "CLM-0011"
          ],
          "synthetic_reason": "Synthetic staging laparoscopy before any attempt at resection; echoes the documented exploratory operation.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "PROC-007",
        "display": "Biopsy of peritoneal nodules at staging laparoscopy",
        "status": "completed",
        "coding": [
          {
            "system": "http://snomed.info/sct",
            "code": "238305001",
            "display": "Biopsy of lesion of peritoneal cavity",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "period": {
          "start": "2026-05-27",
          "end": "2026-05-27"
        },
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0011"
          ],
          "synthetic_reason": "Synthetic biopsy confirming peritoneal metastases.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "PROC-008",
        "display": "Implanted venous access port placed under the same anesthetic",
        "status": "completed",
        "coding": [
          {
            "system": "http://snomed.info/sct",
            "code": "80402001",
            "display": "Implantation of venous access port",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "period": {
          "start": "2026-05-27",
          "end": "2026-05-27"
        },
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic port for chemotherapy.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "PROC-009",
        "display": "Multidisciplinary hepatobiliary tumor board review after staging laparoscopy",
        "status": "completed",
        "coding": [
          {
            "system": "http://snomed.info/sct",
            "code": "384682003",
            "display": "Multidisciplinary care conference",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "period": {
          "start": "2026-05-29",
          "end": "2026-05-29"
        },
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic tumor board recommending systemic therapy.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "PROC-010",
        "display": "Restaging contrast CT of the chest, abdomen and pelvis after three cycles",
        "status": "completed",
        "coding": [
          {
            "system": "http://snomed.info/sct",
            "code": "429864007",
            "display": "CT of thorax and abdomen with contrast",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "period": {
          "start": "2026-07-30",
          "end": "2026-07-30"
        },
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic restaging.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "PROC-011",
        "display": "Restaging contrast CT of the chest, abdomen and pelvis after seven cycles",
        "status": "completed",
        "coding": [
          {
            "system": "http://snomed.info/sct",
            "code": "429864007",
            "display": "CT of thorax and abdomen with contrast",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "period": {
          "start": "2026-10-22",
          "end": "2026-10-22"
        },
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic restaging.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "PROC-012",
        "display": "Advance care planning conversation, about 25 minutes",
        "status": "completed",
        "coding": [
          {
            "system": "http://snomed.info/sct",
            "code": "713603004",
            "display": "Advance care planning",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "period": {
          "start": "2026-09-21",
          "end": "2026-09-21"
        },
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic voluntary advance care planning; records only his own general preferences.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      }
    ],
    "immunizations": [
      {
        "id": "IMM-001",
        "display": "Influenza vaccine, 2026-2027 season (inactivated)",
        "status": "completed",
        "date": "2026-09-21",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/cvx",
            "code": "140",
            "display": "Influenza, split virus, trivalent, PF",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic yearly inactivated influenza vaccination during chemotherapy.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "IMM-002",
        "display": "COVID-19 vaccine, 2026-2027 formula",
        "status": "completed",
        "date": "2026-09-21",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/cvx",
            "code": "309",
            "display": "COVID-19, mRNA, LNP-S, PF, tris-sucrose, 30 mcg/0.3 mL",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic COVID-19 vaccination for an adult with cancer on treatment.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "IMM-003",
        "display": "Pneumococcal conjugate vaccine (PCV20), for immunosuppression by chemotherapy",
        "status": "completed",
        "date": "2026-09-21",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/cvx",
            "code": "216",
            "display": "Pneumococcal conjugate PCV20, polysaccharide CRM197 conjugate, adjuvant, PF",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic pneumococcal vaccination for an immunocompromised adult.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "IMM-004",
        "display": "Recombinant zoster vaccine, first of two doses",
        "status": "completed",
        "date": "2026-10-26",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/cvx",
            "code": "187",
            "display": "zoster recombinant",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic first zoster dose for an immunocompromised adult, planned at the preventive visit.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      }
    ],
    "family_history": [],
    "past_medical_history": [],
    "encounters": [
      {
        "id": "ENC-001",
        "display": "New patient with a right upper abdominal mass, aching and weight loss: work-up of a liver mass, symptom care, and how he wants to receive results",
        "status": "finished",
        "date": "2026-05-04",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic modern EHR encounter.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "ENC-002",
        "display": "Biopsy and imaging results and medical oncology consultation; diagnosis, staging plan, and hepatitis B status",
        "status": "finished",
        "date": "2026-05-18",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic modern EHR encounter.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        },
        "visit_type": "chronic_care",
        "type_coding": {
          "system": "http://snomed.info/sct",
          "code": "390906007",
          "display": "Follow-up encounter",
          "validation_status": "validated",
          "validated_on": "2026-11-04"
        },
        "documentation": {
          "chief_complaint": "Results of the liver mass work-up and medical oncology consultation",
          "hpi": {
            "narrative": "Mr. Sun returns two weeks after his first visit and is seen the same day by Dr. Choi of medical oncology. He had the multiphase CT eleven days ago, the MRI with MRCP a week ago and the ultrasound-guided core biopsy five days ago; the biopsy site was sore for a day. He asked to see the images and went through them with Dr. Huang and Dr. Choi. The ache under his right ribs is 2 of 10 on acetaminophen once or twice a day, and he is eating five small meals a day. He has had no jaundice, itching, dark urine, fever or vomiting. He is still working full days and asked for a plain account of the findings and the choices.",
            "elements": [
              {
                "label": "Tests done",
                "value": "Multiphase CT, MRI with MRCP, core biopsy of the liver mass"
              },
              {
                "label": "Pain",
                "value": "2 of 10 on acetaminophen once or twice a day"
              },
              {
                "label": "Appetite and weight",
                "value": "Five small meals a day; weight 60.6 kg"
              },
              {
                "label": "Associated signs and symptoms",
                "value": "No jaundice, itching, dark urine, fever, or vomiting"
              },
              {
                "label": "His request",
                "value": "To see the images and hear the findings and choices plainly"
              }
            ]
          },
          "ros": [
            {
              "system": "Constitutional",
              "status": "positive",
              "finding": "Weight down a further 0.4 kg; tired in the evenings; no fever"
            },
            {
              "system": "Gastrointestinal",
              "status": "positive",
              "finding": "Ache under the right ribs, 2 of 10; early fullness; no vomiting, jaundice, or pale stools"
            },
            {
              "system": "Respiratory",
              "status": "negative",
              "finding": "No cough or breathlessness"
            },
            {
              "system": "Integumentary",
              "status": "negative",
              "finding": "No itching; biopsy site healed"
            }
          ],
          "exam": [
            {
              "system": "General",
              "finding": "Thin, well; blood pressure 128/82, pulse 86; weight 60.6 kg; no jaundice"
            },
            {
              "system": "Abdomen",
              "finding": "Firm, non-tender mass felt 4 cm below the right costal margin, moving with breathing; no ascites; no splenomegaly"
            },
            {
              "system": "Lymph nodes",
              "finding": "No supraclavicular or umbilical nodes"
            }
          ],
          "assessment_plan": [
            {
              "problem_id": "PRB-002",
              "display": "Adenocarcinoma of the gallbladder invading the liver",
              "assessment": "CT and MRI show a 7.1 cm mass arising from the gallbladder fundus and invading liver segments IVb and V, with gallstones and two enlarged hepatoduodenal ligament nodes (1.6 and 1.3 cm); the bile ducts are not dilated, the main portal vein and hepatic artery are free, and there are no other liver lesions. The liver is smooth, without cirrhosis. CT of the chest shows only a 6 mm calcified granuloma in the right upper lobe. The core biopsy shows moderately differentiated adenocarcinoma, CK7 positive, CK20 and CDX2 negative, consistent with a pancreatobiliary origin; with the imaging, this is a primary gallbladder adenocarcinoma, not a primary liver cancer. Alpha-fetoprotein is normal and CA 19-9 412 U/mL. Clinical T3 N1 M0 (stage IIIB) on imaging. Liver function is preserved: Child-Pugh A6 (albumin 3.4 g/dL), ALBI grade 2, bilirubin and INR normal. Dr. Choi recommends tumor board review and a staging laparoscopy before any attempt at resection, because peritoneal disease is often not seen on CT in this cancer, and genomic profiling of the biopsy tissue. He agreed",
              "plan": [
                "Tumor board review in two days",
                "Staging laparoscopy, with an implanted port under the same anesthetic, in about ten days",
                "Comprehensive genomic profiling of the biopsy tissue",
                "Specialist palliative care introduced; he would like to meet the team once staging is complete",
                "Acetaminophen and small frequent meals; dietitian appointment"
              ]
            },
            {
              "problem_id": "PRB-001",
              "display": "Right upper quadrant abdominal mass with weight loss",
              "assessment": "Superseded by the biopsy diagnosis of gallbladder adenocarcinoma",
              "plan": [
                "Problem resolved"
              ]
            },
            {
              "problem_id": "PRB-003",
              "display": "Resolved hepatitis B infection",
              "assessment": "Hepatitis B surface antigen negative, total core antibody positive, surface antibody 85 mIU/mL, and HBV DNA undetectable (drawn with the CT): resolved past infection with no liver damage. Hepatitis C antibody negative. Chemotherapy and immunotherapy carry a small risk of reactivation; monitoring with prompt treatment is reasonable rather than routine antiviral prophylaxis",
              "plan": [
                "HBV DNA and ALT every 3 months during treatment and for 6 to 12 months after",
                "Entecavir at once if HBV DNA becomes detectable or surface antigen reappears"
              ]
            }
          ],
          "monitoring": [
            {
              "domain": "imaging",
              "measure": "Multiphase contrast CT or MRI of the liver",
              "cadence": "At presentation of a liver mass",
              "status": "completed_today",
              "detail": "Mass arises from the gallbladder and invades segments IVb and V; non-cirrhotic liver; no other liver lesions",
              "guideline_ids": [
                "GL-AASLD-HCC-2023",
                "GL-NCCN-BIL-2026"
              ]
            },
            {
              "domain": "imaging",
              "measure": "CT of the chest, abdomen and pelvis",
              "cadence": "At staging, then every 2 to 3 months on treatment",
              "status": "completed_today",
              "detail": "Two enlarged hepatoduodenal ligament nodes; no distant disease on CT; 6 mm calcified lung granuloma",
              "guideline_ids": [
                "GL-NCCN-BIL-2026"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Core biopsy of the mass",
              "cadence": "When imaging cannot make the diagnosis (non-cirrhotic liver)",
              "status": "completed_today",
              "detail": "Adenocarcinoma, CK7 positive, CK20 and CDX2 negative: pancreatobiliary origin",
              "guideline_ids": [
                "GL-AASLD-HCC-2023",
                "GL-NCCN-BIL-2026"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Alpha-fetoprotein",
              "cadence": "At presentation of a liver mass",
              "status": "up_to_date",
              "detail": "3.2 ng/mL at intake; normal",
              "guideline_ids": [
                "GL-AASLD-HCC-2023"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "CA 19-9 (and CEA when raised)",
              "cadence": "At diagnosis, then with each cycle or restaging",
              "status": "up_to_date",
              "detail": "CA 19-9 412 U/mL and CEA 8.6 ng/mL at intake",
              "guideline_ids": [
                "GL-NCCN-BIL-2026"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Liver function: Child-Pugh and ALBI",
              "cadence": "At diagnosis, then before each treatment decision",
              "status": "completed_today",
              "detail": "Child-Pugh A6; ALBI grade 2; bilirubin 0.9 mg/dL and INR 1.0 at intake",
              "guideline_ids": [
                "GL-AASLD-HCC-2023"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Hepatitis B and C serology",
              "cadence": "Before chemotherapy or immunotherapy",
              "status": "completed_today",
              "detail": "Surface antigen negative, core antibody positive, surface antibody positive, HBV DNA undetectable; hepatitis C antibody negative",
              "guideline_ids": [
                "GL-ASCO-HBV-2020",
                "GL-AASLD-HCC-2023"
              ]
            },
            {
              "domain": "survey",
              "measure": "ECOG performance status",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "ECOG 1",
              "observation_ids": [
                "OBS-ECOG-V2"
              ],
              "guideline_ids": [
                "GL-NCCN-BIL-2026"
              ]
            },
            {
              "domain": "examination",
              "measure": "Weight and nutrition",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "60.6 kg, down 0.4 kg in two weeks; dietitian booked",
              "guideline_ids": [
                "GL-NCCN-BIL-2026"
              ]
            },
            {
              "domain": "survey",
              "measure": "Pain",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "2 of 10 on acetaminophen",
              "guideline_ids": [
                "GL-ASCO-PALL-2017"
              ]
            },
            {
              "domain": "referral",
              "measure": "Multidisciplinary tumor board",
              "cadence": "Before treatment of a biliary tract cancer",
              "status": "ordered",
              "detail": "In two days",
              "guideline_ids": [
                "GL-NCCN-BIL-2026"
              ]
            },
            {
              "domain": "imaging",
              "measure": "Staging laparoscopy",
              "cadence": "Before resection of gallbladder cancer",
              "status": "ordered",
              "detail": "In about ten days, with a port",
              "guideline_ids": [
                "GL-NCCN-BIL-2026"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Comprehensive genomic profiling of tumor tissue",
              "cadence": "At diagnosis of advanced disease",
              "status": "ordered",
              "detail": "Sent on the biopsy tissue",
              "guideline_ids": [
                "GL-NCCN-BIL-2026"
              ]
            },
            {
              "domain": "referral",
              "measure": "Medical oncology",
              "cadence": "At diagnosis",
              "status": "completed_today",
              "detail": "Seen by Dr. Choi today",
              "guideline_ids": [
                "GL-NCCN-BIL-2026"
              ]
            },
            {
              "domain": "referral",
              "measure": "Specialist palliative care",
              "cadence": "From the diagnosis of advanced cancer",
              "status": "due",
              "detail": "Introduced today; first meeting after staging, at his choice",
              "guideline_ids": [
                "GL-ASCO-PALL-2017"
              ]
            }
          ],
          "follow_up": "Tumor board in two days; staging laparoscopy in about ten days. Visit in two weeks with the result and the tumor board recommendation",
          "guideline_ids": [
            "GL-NCCN-BIL-2026",
            "GL-AASLD-HCC-2023",
            "GL-ASCO-HBV-2020",
            "GL-ASCO-PALL-2017"
          ]
        }
      },
      {
        "id": "ENC-003",
        "display": "Staging laparoscopy result and tumor board recommendation; first cycle of chemoimmunotherapy and specialist palliative care",
        "status": "finished",
        "date": "2026-06-01",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic modern EHR encounter.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        },
        "visit_type": "chronic_care",
        "type_coding": {
          "system": "http://snomed.info/sct",
          "code": "390906007",
          "display": "Follow-up encounter",
          "validation_status": "validated",
          "validated_on": "2026-11-04"
        },
        "documentation": {
          "chief_complaint": "Staging laparoscopy result, tumor board recommendation, and first cycle of treatment",
          "hpi": {
            "narrative": "Mr. Sun returns two weeks after the consultation and five days after the staging laparoscopy. At laparoscopy the surgeon found several small nodules on the lining of the abdomen and the omentum, and their biopsy shows adenocarcinoma of the same type. The tumor board met two days later and advised against an operation and for chemoimmunotherapy. He has recovered from the laparoscopy; the port and the small wounds are healing. The ache under his ribs is unchanged at 2 of 10. He said he had expected this, as a physician, but found it hard to hear. He has slept poorly for several nights. He wants to start treatment today if he is fit for it and asked how long treatment might keep him working.",
            "elements": [
              {
                "label": "Staging laparoscopy",
                "value": "Peritoneal and omental nodules; biopsy adenocarcinoma"
              },
              {
                "label": "Tumor board",
                "value": "Not resectable; first-line chemoimmunotherapy advised"
              },
              {
                "label": "Recovery",
                "value": "Wounds and port healing"
              },
              {
                "label": "Mood and sleep",
                "value": "Finds the news hard; sleeping poorly"
              },
              {
                "label": "His question",
                "value": "How long treatment may keep him working"
              }
            ]
          },
          "ros": [
            {
              "system": "Constitutional",
              "status": "positive",
              "finding": "Tired; weight 60.0 kg; no fever"
            },
            {
              "system": "Gastrointestinal",
              "status": "positive",
              "finding": "Ache under the right ribs 2 of 10; no jaundice or vomiting"
            },
            {
              "system": "Psychiatric",
              "status": "positive",
              "finding": "Low at times and sleeping poorly since the result; no thoughts of self-harm"
            },
            {
              "system": "Integumentary",
              "status": "negative",
              "finding": "Port and laparoscopy wounds healing without redness"
            }
          ],
          "exam": [
            {
              "system": "General",
              "finding": "Thin, composed; blood pressure 126/80, pulse 84; weight 60.0 kg; no jaundice"
            },
            {
              "system": "Abdomen",
              "finding": "Healing laparoscopy wounds; mass 4 cm below the right costal margin, unchanged; no ascites"
            },
            {
              "system": "Chest wall",
              "finding": "Port site clean and dry"
            },
            {
              "system": "Ears, nose, mouth, and throat",
              "finding": "Hears a whispered voice in both ears"
            }
          ],
          "assessment_plan": [
            {
              "problem_id": "PRB-004",
              "display": "Peritoneal metastases from gallbladder adenocarcinoma",
              "assessment": "Peritoneal metastases confirmed by biopsy: stage IVB (any T, any N, M1). Not resectable; treatment aims to control the cancer, relieve symptoms and lengthen life, not to cure",
              "plan": [
                "Systemic therapy as below",
                "Restaging CT after three cycles"
              ]
            },
            {
              "problem_id": "PRB-002",
              "display": "Gallbladder adenocarcinoma, stage IVB",
              "assessment": "ECOG 1, Child-Pugh A6, bilirubin 0.8 mg/dL, creatinine 0.84 mg/dL (estimated creatinine clearance about 80 mL/min), neutrophils 4.9 x10^3/uL and platelets 318 x10^3/uL: fit for gemcitabine, cisplatin and durvalumab, the first-line regimen Dr. Choi and the tumor board recommend. Baseline TSH 1.9 and CA 19-9 498 U/mL. Genomic profiling is pending. He chose to start today",
              "plan": [
                "Cycle 1 day 1 today: gemcitabine 1,000 mg/m2 and cisplatin 25 mg/m2 on days 1 and 8 with durvalumab 1,500 mg on day 1, every 21 days, for up to 8 cycles, then durvalumab every 4 weeks",
                "Ondansetron at home for nausea",
                "Teaching on fever, infection and immune-related side effects; oncology line number given",
                "Restaging CT after three cycles"
              ]
            },
            {
              "problem_id": "PRB-003",
              "display": "Resolved hepatitis B infection",
              "assessment": "HBV DNA undetectable before treatment",
              "plan": [
                "HBV DNA and ALT in about 2 to 3 months"
              ]
            },
            {
              "display": "Coping with a new diagnosis of advanced cancer",
              "assessment": "PHQ-9 6 (mild), with low mood and poor sleep since the result and no thoughts of self-harm; an expected reaction to grave news. Specialist palliative care starts now alongside treatment",
              "plan": [
                "First palliative care visit next week",
                "Sleep advice; review the PHQ-9 at the next visit"
              ]
            }
          ],
          "monitoring": [
            {
              "domain": "imaging",
              "measure": "Staging laparoscopy",
              "cadence": "Before resection of gallbladder cancer",
              "status": "completed_today",
              "detail": "Peritoneal and omental nodules; biopsy adenocarcinoma: M1",
              "guideline_ids": [
                "GL-NCCN-BIL-2026"
              ]
            },
            {
              "domain": "referral",
              "measure": "Multidisciplinary tumor board",
              "cadence": "Before treatment, and when the stage changes",
              "status": "completed_today",
              "detail": "Not resectable; gemcitabine, cisplatin and durvalumab advised",
              "guideline_ids": [
                "GL-NCCN-BIL-2026"
              ]
            },
            {
              "domain": "imaging",
              "measure": "CT of the chest, abdomen and pelvis",
              "cadence": "At staging, then every 2 to 3 months on treatment",
              "status": "due",
              "detail": "Baseline from staging; restaging after three cycles",
              "guideline_ids": [
                "GL-NCCN-BIL-2026",
                "GL-TOPAZ1-2022"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "CA 19-9 (and CEA when raised)",
              "cadence": "At diagnosis, then with each cycle or restaging",
              "status": "completed_today",
              "detail": "CA 19-9 498 U/mL at baseline",
              "observation_ids": [
                "OBS-CA199-V3"
              ],
              "guideline_ids": [
                "GL-NCCN-BIL-2026",
                "GL-TOPAZ1-2022"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Blood count with neutrophils",
              "cadence": "Before every dose (days 1 and 8)",
              "status": "completed_today",
              "detail": "White cells 7.4, neutrophils 4.9, hemoglobin 12.2 g/dL, platelets 318",
              "observation_ids": [
                "OBS-WBC-V3",
                "OBS-ANC-V3",
                "OBS-HGB-V3",
                "OBS-PLT-V3"
              ],
              "guideline_ids": [
                "GL-NCCN-BIL-2026",
                "GL-TOPAZ1-2022"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Creatinine and eGFR",
              "cadence": "Before every dose (days 1 and 8)",
              "status": "completed_today",
              "detail": "Creatinine 0.84 mg/dL, eGFR 102; adequate for cisplatin",
              "observation_ids": [
                "OBS-CR-V3",
                "OBS-EGFR-V3"
              ],
              "guideline_ids": [
                "GL-NCCN-BIL-2026",
                "GL-TOPAZ1-2022"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Magnesium and potassium",
              "cadence": "Before every dose (days 1 and 8)",
              "status": "completed_today",
              "detail": "Magnesium 2.0 mg/dL, potassium 4.3 mmol/L, sodium 137 mmol/L",
              "observation_ids": [
                "OBS-MG-V3",
                "OBS-K-V3",
                "OBS-NA-V3"
              ],
              "guideline_ids": [
                "GL-NCCN-BIL-2026",
                "GL-TOPAZ1-2022"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Liver tests (bilirubin, alkaline phosphatase, AST, ALT, albumin)",
              "cadence": "Before every dose (days 1 and 8)",
              "status": "completed_today",
              "detail": "Bilirubin 0.8 mg/dL, alkaline phosphatase 236, AST 52, ALT 44 U/L, albumin 3.4 g/dL",
              "observation_ids": [
                "OBS-TBIL-V3",
                "OBS-ALP-V3",
                "OBS-AST-V3",
                "OBS-ALT-V3",
                "OBS-ALB-V3"
              ],
              "guideline_ids": [
                "GL-NCCN-BIL-2026",
                "GL-TOPAZ1-2022",
                "GL-ASCO-IRAE-2021"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "TSH",
              "cadence": "Baseline, then every 4 to 6 weeks on durvalumab",
              "status": "completed_today",
              "detail": "1.9 mIU/L at baseline",
              "observation_ids": [
                "OBS-TSH-V3"
              ],
              "guideline_ids": [
                "GL-ASCO-IRAE-2021"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Glucose",
              "cadence": "Baseline, then with each pre-dose chemistry panel on durvalumab",
              "status": "deferred",
              "detail": "Missed: today's pre-treatment panel was ordered as a renal panel with magnesium and did not include glucose. Glucose was 98 mg/dL at intake and he has no thirst or excess urination, so no harm is apparent. Corrective action: glucose added to the standing pre-dose order from the next draw",
              "guideline_ids": [
                "GL-ASCO-IRAE-2021"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "HBV DNA and ALT (resolved hepatitis B)",
              "cadence": "Every 3 months during treatment and for 6 to 12 months after",
              "status": "up_to_date",
              "detail": "HBV DNA undetectable before treatment; ALT 44 U/L today (liver tests above); next in 2 to 3 months",
              "guideline_ids": [
                "GL-ASCO-HBV-2020"
              ]
            },
            {
              "domain": "examination",
              "measure": "Hearing (cisplatin)",
              "cadence": "Baseline before cisplatin, then by symptoms each cycle",
              "status": "deferred",
              "detail": "Missed: no baseline audiogram before the first cisplatin dose; whispered-voice test normal today and no hearing symptoms. The lower 25 mg/m2 dose carries less risk; corrective action is to ask about hearing at each cycle and obtain an audiogram for any change",
              "guideline_ids": [
                "GL-NCCN-BIL-2026",
                "GL-TOPAZ1-2022"
              ]
            },
            {
              "domain": "survey",
              "measure": "ECOG performance status",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "ECOG 1",
              "observation_ids": [
                "OBS-ECOG-V3"
              ],
              "guideline_ids": [
                "GL-NCCN-BIL-2026",
                "GL-TOPAZ1-2022"
              ]
            },
            {
              "domain": "examination",
              "measure": "Weight and nutrition",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "60.0 kg; dietitian advice followed",
              "guideline_ids": [
                "GL-NCCN-BIL-2026"
              ]
            },
            {
              "domain": "survey",
              "measure": "Pain",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "2 of 10 on acetaminophen",
              "guideline_ids": [
                "GL-ASCO-PALL-2017"
              ]
            },
            {
              "domain": "survey",
              "measure": "Distress and depression (PHQ-9)",
              "cadence": "At diagnosis and at each change in treatment",
              "status": "completed_today",
              "detail": "PHQ-9 6, mild; no thoughts of self-harm",
              "observation_ids": [
                "OBS-PHQ9-V3"
              ],
              "guideline_ids": [
                "GL-ASCO-PALL-2017"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Comprehensive genomic profiling of tumor tissue",
              "cadence": "At diagnosis of advanced disease",
              "status": "ordered",
              "detail": "Pending",
              "guideline_ids": [
                "GL-NCCN-BIL-2026"
              ]
            },
            {
              "domain": "referral",
              "measure": "Specialist palliative care",
              "cadence": "From the diagnosis of advanced cancer",
              "status": "referred",
              "detail": "First visit next week",
              "guideline_ids": [
                "GL-ASCO-PALL-2017"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "Immune-related side effects (diarrhea, rash, cough or breathlessness, fatigue, endocrine symptoms)",
              "cadence": "Teaching before the first dose, then every visit",
              "status": "completed_today",
              "detail": "Taught today with written information",
              "guideline_ids": [
                "GL-ASCO-IRAE-2021"
              ]
            }
          ],
          "follow_up": "Cycle 1 day 8 next week; palliative care next week. Visit before cycle 4 with a restaging CT",
          "guideline_ids": [
            "GL-NCCN-BIL-2026",
            "GL-TOPAZ1-2022",
            "GL-ASCO-IRAE-2021",
            "GL-ASCO-HBV-2020",
            "GL-ASCO-PALL-2017"
          ]
        }
      },
      {
        "id": "ENC-004",
        "display": "Before cycle 4: restaging CT, tumor marker, toxicity review, hepatitis B monitoring, and genomic profiling result",
        "status": "finished",
        "date": "2026-08-03",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic modern EHR encounter.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        },
        "visit_type": "chronic_care",
        "type_coding": {
          "system": "http://snomed.info/sct",
          "code": "390906007",
          "display": "Follow-up encounter",
          "validation_status": "validated",
          "validated_on": "2026-11-04"
        },
        "documentation": {
          "chief_complaint": "Before cycle 4: restaging CT, tumor marker, side effects, and genomic profiling result",
          "hpi": {
            "narrative": "Mr. Sun returns before cycle 4, nine weeks after starting treatment. He has had all three cycles on schedule. He is nauseated on the two days after each infusion, which ondansetron controls, and tired for three or four days after each day-8 dose; otherwise he works most days. He has no diarrhea, rash, cough or breathlessness, no numbness or tingling, and no ringing in the ears or change in hearing. The ache under his ribs is 1 to 2 of 10 and he takes acetaminophen only a few times a week. He has seen the palliative care team twice and says it helped him sleep and think about his priorities. The restaging CT four days ago and the HBV DNA drawn with it are back, and so is the genomic profiling of his tumor.",
            "elements": [
              {
                "label": "Cycles",
                "value": "Three, all on schedule"
              },
              {
                "label": "Side effects",
                "value": "Nausea two days after infusions, controlled; tiredness after day-8 doses"
              },
              {
                "label": "Immune-related symptoms",
                "value": "None"
              },
              {
                "label": "Pain",
                "value": "1 to 2 of 10; acetaminophen a few times a week"
              },
              {
                "label": "Palliative care",
                "value": "Two visits; sleep and coping better"
              }
            ]
          },
          "ros": [
            {
              "system": "Constitutional",
              "status": "positive",
              "finding": "Tired after day-8 doses; weight 59.2 kg; no fever"
            },
            {
              "system": "Gastrointestinal",
              "status": "positive",
              "finding": "Nausea for two days after infusions; no diarrhea or jaundice"
            },
            {
              "system": "Ears, nose, mouth, and throat",
              "status": "negative",
              "finding": "No tinnitus or hearing change; no mouth sores"
            },
            {
              "system": "Respiratory",
              "status": "negative",
              "finding": "No cough or breathlessness"
            },
            {
              "system": "Integumentary",
              "status": "negative",
              "finding": "No rash or itching"
            },
            {
              "system": "Neurological",
              "status": "negative",
              "finding": "No numbness or tingling"
            },
            {
              "system": "Psychiatric",
              "status": "negative",
              "finding": "Mood steadier; sleeping better; PHQ-9 5"
            }
          ],
          "exam": [
            {
              "system": "General",
              "finding": "Thin, well; blood pressure 122/78, pulse 82; weight 59.2 kg; no jaundice"
            },
            {
              "system": "Abdomen",
              "finding": "Liver edge firm, 3 cm below the right costal margin, smaller than at diagnosis; no ascites"
            },
            {
              "system": "Skin",
              "finding": "No rash; port site clean"
            },
            {
              "system": "Neurological",
              "finding": "Light touch and vibration normal in the fingers and toes"
            }
          ],
          "assessment_plan": [
            {
              "problem_id": "PRB-002",
              "display": "Gallbladder adenocarcinoma, stage IVB, on chemoimmunotherapy",
              "assessment": "Restaging CT: the gallbladder and liver mass is 5.6 cm (7.1 cm at baseline), the hepatoduodenal nodes 1.1 and 0.9 cm, and the peritoneal nodules smaller; no new lesions. The sum of target lesions has fallen 24%, stable disease by RECIST with shrinkage. CA 19-9 168 U/mL, from 498. Side effects grade 1 (nausea, fatigue); hemoglobin 10.9 g/dL (grade 1 anemia). Genomic profiling: microsatellite stable and mismatch-repair proficient, HER2 not amplified, no FGFR2 fusion, IDH1, BRAF and KRAS wild-type, a TP53 mutation, tumor mutational burden 4 per megabase: no targeted treatment option now. TSH 2.4 and glucose 94 mg/dL",
              "plan": [
                "Cycle 4 today, unchanged doses",
                "Continue to 8 cycles, then durvalumab every 4 weeks",
                "Restaging CT after cycle 7"
              ]
            },
            {
              "problem_id": "PRB-004",
              "display": "Peritoneal metastases",
              "assessment": "Smaller on CT; no ascites",
              "plan": [
                "Followed on restaging CT"
              ]
            },
            {
              "problem_id": "PRB-003",
              "display": "Resolved hepatitis B infection",
              "assessment": "HBV DNA undetectable four days ago; ALT 30 U/L. No reactivation",
              "plan": [
                "Repeat HBV DNA and ALT in about 3 months"
              ]
            }
          ],
          "monitoring": [
            {
              "domain": "imaging",
              "measure": "CT of the chest, abdomen and pelvis",
              "cadence": "At staging, then every 2 to 3 months on treatment",
              "status": "completed_today",
              "detail": "Four days ago: mass 5.6 cm from 7.1 cm; nodes and peritoneal nodules smaller; no new lesions; stable disease, sum down 24%",
              "guideline_ids": [
                "GL-NCCN-BIL-2026",
                "GL-TOPAZ1-2022"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "CA 19-9 (and CEA when raised)",
              "cadence": "At diagnosis, then with each cycle or restaging",
              "status": "completed_today",
              "detail": "CA 19-9 168 U/mL, from 498",
              "observation_ids": [
                "OBS-CA199-V4"
              ],
              "guideline_ids": [
                "GL-NCCN-BIL-2026",
                "GL-TOPAZ1-2022"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Blood count with neutrophils",
              "cadence": "Before every dose (days 1 and 8)",
              "status": "completed_today",
              "detail": "White cells 4.6, neutrophils 2.4, hemoglobin 10.9 g/dL (grade 1 anemia), platelets 188; adequate for treatment",
              "observation_ids": [
                "OBS-WBC-V4",
                "OBS-ANC-V4",
                "OBS-HGB-V4",
                "OBS-PLT-V4"
              ],
              "guideline_ids": [
                "GL-NCCN-BIL-2026",
                "GL-TOPAZ1-2022"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Creatinine and eGFR",
              "cadence": "Before every dose (days 1 and 8)",
              "status": "completed_today",
              "detail": "Creatinine 0.92 mg/dL, eGFR 97",
              "observation_ids": [
                "OBS-CR-V4",
                "OBS-EGFR-V4"
              ],
              "guideline_ids": [
                "GL-NCCN-BIL-2026",
                "GL-TOPAZ1-2022"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Magnesium and potassium",
              "cadence": "Before every dose (days 1 and 8)",
              "status": "completed_today",
              "detail": "Magnesium 1.7 mg/dL (lower limit), potassium 4.0 mmol/L, sodium 136 mmol/L; dietary magnesium advised",
              "observation_ids": [
                "OBS-MG-V4",
                "OBS-K-V4",
                "OBS-NA-V4"
              ],
              "guideline_ids": [
                "GL-NCCN-BIL-2026",
                "GL-TOPAZ1-2022"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Liver tests (bilirubin, alkaline phosphatase, AST, ALT, albumin)",
              "cadence": "Before every dose (days 1 and 8)",
              "status": "completed_today",
              "detail": "Bilirubin 0.7 mg/dL, alkaline phosphatase 158, AST 34, ALT 30 U/L, albumin 3.6 g/dL; improving",
              "observation_ids": [
                "OBS-TBIL-V4",
                "OBS-ALP-V4",
                "OBS-AST-V4",
                "OBS-ALT-V4",
                "OBS-ALB-V4"
              ],
              "guideline_ids": [
                "GL-NCCN-BIL-2026",
                "GL-TOPAZ1-2022",
                "GL-ASCO-IRAE-2021"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "TSH",
              "cadence": "Baseline, then every 4 to 6 weeks on durvalumab",
              "status": "completed_today",
              "detail": "2.4 mIU/L",
              "observation_ids": [
                "OBS-TSH-V4"
              ],
              "guideline_ids": [
                "GL-ASCO-IRAE-2021"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Glucose",
              "cadence": "Baseline, then with each pre-dose chemistry panel on durvalumab",
              "status": "completed_today",
              "detail": "94 mg/dL; on the standing pre-dose order since cycle 1 day 8, after the gap at cycle 1 day 1",
              "observation_ids": [
                "OBS-GLU-V4"
              ],
              "guideline_ids": [
                "GL-ASCO-IRAE-2021"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "HBV DNA and ALT (resolved hepatitis B)",
              "cadence": "Every 3 months during treatment and for 6 to 12 months after",
              "status": "completed_today",
              "detail": "HBV DNA undetectable four days ago; ALT 30 U/L",
              "guideline_ids": [
                "GL-ASCO-HBV-2020"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "Immune-related side effects (diarrhea, rash, cough or breathlessness, fatigue, endocrine symptoms)",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "No diarrhea, rash, cough, breathlessness or endocrine symptoms",
              "guideline_ids": [
                "GL-ASCO-IRAE-2021"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "Chemotherapy side effects: nausea, fatigue, neuropathy, hearing",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "Grade 1 nausea and fatigue; no neuropathy",
              "guideline_ids": [
                "GL-NCCN-BIL-2026",
                "GL-TOPAZ1-2022"
              ]
            },
            {
              "domain": "examination",
              "measure": "Hearing (cisplatin)",
              "cadence": "Baseline before cisplatin, then by symptoms each cycle",
              "status": "completed_today",
              "detail": "No tinnitus or hearing change; whispered voice heard",
              "guideline_ids": [
                "GL-NCCN-BIL-2026",
                "GL-TOPAZ1-2022"
              ]
            },
            {
              "domain": "survey",
              "measure": "ECOG performance status",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "ECOG 1",
              "observation_ids": [
                "OBS-ECOG-V4"
              ],
              "guideline_ids": [
                "GL-NCCN-BIL-2026",
                "GL-TOPAZ1-2022"
              ]
            },
            {
              "domain": "examination",
              "measure": "Weight and nutrition",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "59.2 kg, 0.8 kg below the start of treatment",
              "guideline_ids": [
                "GL-NCCN-BIL-2026"
              ]
            },
            {
              "domain": "survey",
              "measure": "Pain",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "1 to 2 of 10",
              "guideline_ids": [
                "GL-ASCO-PALL-2017"
              ]
            },
            {
              "domain": "survey",
              "measure": "Distress and depression (PHQ-9)",
              "cadence": "At each change in treatment or status",
              "status": "completed_today",
              "detail": "PHQ-9 5",
              "observation_ids": [
                "OBS-PHQ9-V4"
              ],
              "guideline_ids": [
                "GL-ASCO-PALL-2017"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Comprehensive genomic profiling of tumor tissue",
              "cadence": "At diagnosis of advanced disease",
              "status": "completed_today",
              "detail": "No targetable alteration; microsatellite stable",
              "guideline_ids": [
                "GL-NCCN-BIL-2026"
              ]
            },
            {
              "domain": "referral",
              "measure": "Specialist palliative care",
              "cadence": "From the diagnosis of advanced cancer",
              "status": "completed_today",
              "detail": "Two visits; ongoing every 3 to 4 weeks",
              "guideline_ids": [
                "GL-ASCO-PALL-2017"
              ]
            }
          ],
          "follow_up": "Cycles 4 to 7 as scheduled. Visit before cycle 8 with a restaging CT, HBV DNA and ALT",
          "guideline_ids": [
            "GL-NCCN-BIL-2026",
            "GL-TOPAZ1-2022",
            "GL-ASCO-IRAE-2021",
            "GL-ASCO-HBV-2020",
            "GL-ASCO-PALL-2017"
          ]
        }
      },
      {
        "id": "ENC-005",
        "display": "Before cycle 8: restaging CT, toxicity review, low magnesium, and the plan for maintenance durvalumab",
        "status": "finished",
        "date": "2026-10-26",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic modern EHR encounter.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        },
        "visit_type": "chronic_care",
        "type_coding": {
          "system": "http://snomed.info/sct",
          "code": "390906007",
          "display": "Follow-up encounter",
          "validation_status": "validated",
          "validated_on": "2026-11-04"
        },
        "documentation": {
          "chief_complaint": "Before cycle 8: restaging CT, side effects, low magnesium, and the plan for maintenance",
          "hpi": {
            "narrative": "Mr. Sun returns before his eighth and last cycle of chemotherapy, five weeks after his preventive visit. Cycles 4 to 7 were given on schedule; the cold he had during cycle 5 settled without fever. For two weeks he has had a light tingling in his fingertips that does not affect buttoning or writing. He has had muscle cramps in his calves at night. He has no diarrhea, rash, cough or breathlessness, and no hearing change. His weight is steady. The ache under his ribs has gone most days. His HIV test from the preventive visit was negative. The restaging CT and HBV DNA four days ago are back.",
            "elements": [
              {
                "label": "Cycles",
                "value": "Seven, on schedule"
              },
              {
                "label": "New symptoms",
                "value": "Fingertip tingling for two weeks; night cramps in the calves"
              },
              {
                "label": "Immune-related symptoms",
                "value": "None"
              },
              {
                "label": "Weight",
                "value": "Steady"
              },
              {
                "label": "Results",
                "value": "HIV test negative; restaging CT and HBV DNA back"
              }
            ]
          },
          "ros": [
            {
              "system": "Constitutional",
              "status": "positive",
              "finding": "Tired after infusions; weight 59.6 kg; no fever"
            },
            {
              "system": "Musculoskeletal",
              "status": "positive",
              "finding": "Night cramps in both calves"
            },
            {
              "system": "Neurological",
              "status": "positive",
              "finding": "Light tingling in the fingertips; no weakness; buttons and writes normally"
            },
            {
              "system": "Ears, nose, mouth, and throat",
              "status": "negative",
              "finding": "No tinnitus or hearing change"
            },
            {
              "system": "Gastrointestinal",
              "status": "negative",
              "finding": "Ache mostly gone; nausea mild after infusions; no diarrhea"
            },
            {
              "system": "Respiratory",
              "status": "negative",
              "finding": "No cough or breathlessness"
            }
          ],
          "exam": [
            {
              "system": "General",
              "finding": "Thin, well; blood pressure 124/78, pulse 80; weight 59.6 kg; no jaundice"
            },
            {
              "system": "Abdomen",
              "finding": "Liver edge 2 cm below the right costal margin; no ascites"
            },
            {
              "system": "Neurological",
              "finding": "Vibration slightly reduced at the fingertips; light touch, strength and reflexes normal"
            },
            {
              "system": "Skin",
              "finding": "No rash; port site clean"
            }
          ],
          "assessment_plan": [
            {
              "problem_id": "PRB-002",
              "display": "Gallbladder adenocarcinoma, stage IVB, on chemoimmunotherapy",
              "assessment": "Restaging CT: mass 4.9 cm; nodes and peritoneal nodules smaller still; no new lesions. The sum of target lesions has fallen 33% from baseline: partial response by RECIST. CA 19-9 121 U/mL. Grade 1 sensory neuropathy from cisplatin, not limiting function; magnesium 1.6 mg/dL with night cramps, from cisplatin; hemoglobin 10.7 g/dL. TSH 3.1",
              "plan": [
                "Cycle 8 today; cisplatin continued because the neuropathy is grade 1 and this is the last cycle",
                "Magnesium oxide 400 mg daily; magnesium with each dose",
                "Durvalumab 1,500 mg every 4 weeks from four weeks after today, until progression or unacceptable toxicity",
                "Restaging CT every 2 to 3 months",
                "Recombinant zoster vaccine today"
              ]
            },
            {
              "problem_id": "PRB-004",
              "display": "Peritoneal metastases",
              "assessment": "Smaller; no ascites",
              "plan": [
                "Followed on restaging CT"
              ]
            },
            {
              "problem_id": "PRB-003",
              "display": "Resolved hepatitis B infection",
              "assessment": "HBV DNA undetectable four days ago; ALT 28 U/L",
              "plan": [
                "HBV DNA and ALT every 3 months on durvalumab and for 6 to 12 months after treatment"
              ]
            }
          ],
          "monitoring": [
            {
              "domain": "imaging",
              "measure": "CT of the chest, abdomen and pelvis",
              "cadence": "At staging, then every 2 to 3 months on treatment",
              "status": "completed_today",
              "detail": "Four days ago: mass 4.9 cm; partial response, sum down 33% from baseline; no new lesions",
              "guideline_ids": [
                "GL-NCCN-BIL-2026",
                "GL-TOPAZ1-2022"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "CA 19-9 (and CEA when raised)",
              "cadence": "At diagnosis, then with each cycle or restaging",
              "status": "completed_today",
              "detail": "CA 19-9 121 U/mL",
              "observation_ids": [
                "OBS-CA199-V5"
              ],
              "guideline_ids": [
                "GL-NCCN-BIL-2026",
                "GL-TOPAZ1-2022"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Blood count with neutrophils",
              "cadence": "Before every dose (days 1 and 8)",
              "status": "completed_today",
              "detail": "White cells 4.3, neutrophils 2.1, hemoglobin 10.7 g/dL, platelets 176",
              "observation_ids": [
                "OBS-WBC-V5",
                "OBS-ANC-V5",
                "OBS-HGB-V5",
                "OBS-PLT-V5"
              ],
              "guideline_ids": [
                "GL-NCCN-BIL-2026",
                "GL-TOPAZ1-2022"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Creatinine and eGFR",
              "cadence": "Before every dose (days 1 and 8)",
              "status": "completed_today",
              "detail": "Creatinine 0.95 mg/dL, eGFR 93",
              "observation_ids": [
                "OBS-CR-V5",
                "OBS-EGFR-V5"
              ],
              "guideline_ids": [
                "GL-NCCN-BIL-2026",
                "GL-TOPAZ1-2022"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Magnesium and potassium",
              "cadence": "Before every dose (days 1 and 8)",
              "status": "completed_today",
              "detail": "Magnesium 1.6 mg/dL (low), potassium 4.1 mmol/L, sodium 137 mmol/L; magnesium oxide started",
              "observation_ids": [
                "OBS-MG-V5",
                "OBS-K-V5",
                "OBS-NA-V5"
              ],
              "guideline_ids": [
                "GL-NCCN-BIL-2026",
                "GL-TOPAZ1-2022"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Liver tests (bilirubin, alkaline phosphatase, AST, ALT, albumin)",
              "cadence": "Before every dose (days 1 and 8)",
              "status": "completed_today",
              "detail": "Bilirubin 0.6 mg/dL, alkaline phosphatase 141, AST 31, ALT 28 U/L, albumin 3.7 g/dL",
              "observation_ids": [
                "OBS-TBIL-V5",
                "OBS-ALP-V5",
                "OBS-AST-V5",
                "OBS-ALT-V5",
                "OBS-ALB-V5"
              ],
              "guideline_ids": [
                "GL-NCCN-BIL-2026",
                "GL-TOPAZ1-2022",
                "GL-ASCO-IRAE-2021"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "TSH",
              "cadence": "Baseline, then every 4 to 6 weeks on durvalumab",
              "status": "completed_today",
              "detail": "3.1 mIU/L",
              "observation_ids": [
                "OBS-TSH-V5"
              ],
              "guideline_ids": [
                "GL-ASCO-IRAE-2021"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Glucose",
              "cadence": "Baseline, then with each pre-dose chemistry panel on durvalumab",
              "status": "completed_today",
              "detail": "96 mg/dL",
              "observation_ids": [
                "OBS-GLU-V5"
              ],
              "guideline_ids": [
                "GL-ASCO-IRAE-2021"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "HBV DNA and ALT (resolved hepatitis B)",
              "cadence": "Every 3 months during treatment and for 6 to 12 months after",
              "status": "completed_today",
              "detail": "HBV DNA undetectable four days ago; ALT 28 U/L",
              "guideline_ids": [
                "GL-ASCO-HBV-2020"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "Immune-related side effects (diarrhea, rash, cough or breathlessness, fatigue, endocrine symptoms)",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "None",
              "guideline_ids": [
                "GL-ASCO-IRAE-2021"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "Chemotherapy side effects: nausea, fatigue, neuropathy, hearing",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "Grade 1 sensory neuropathy; night cramps with low magnesium",
              "guideline_ids": [
                "GL-NCCN-BIL-2026",
                "GL-TOPAZ1-2022"
              ]
            },
            {
              "domain": "examination",
              "measure": "Hearing (cisplatin)",
              "cadence": "Baseline before cisplatin, then by symptoms each cycle",
              "status": "completed_today",
              "detail": "No hearing symptoms; the audiogram is not needed unless symptoms appear",
              "guideline_ids": [
                "GL-NCCN-BIL-2026",
                "GL-TOPAZ1-2022"
              ]
            },
            {
              "domain": "survey",
              "measure": "ECOG performance status",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "ECOG 1",
              "observation_ids": [
                "OBS-ECOG-V5"
              ],
              "guideline_ids": [
                "GL-NCCN-BIL-2026",
                "GL-TOPAZ1-2022"
              ]
            },
            {
              "domain": "examination",
              "measure": "Weight and nutrition",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "59.6 kg, within 0.4 kg of the start of treatment",
              "guideline_ids": [
                "GL-NCCN-BIL-2026"
              ]
            },
            {
              "domain": "survey",
              "measure": "Pain",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "0 to 1 of 10",
              "guideline_ids": [
                "GL-ASCO-PALL-2017"
              ]
            },
            {
              "domain": "survey",
              "measure": "Distress and depression (PHQ-9)",
              "cadence": "At each change in treatment or status",
              "status": "completed_today",
              "detail": "PHQ-9 4",
              "observation_ids": [
                "OBS-PHQ9-V5"
              ],
              "guideline_ids": [
                "GL-ASCO-PALL-2017"
              ]
            },
            {
              "domain": "referral",
              "measure": "Specialist palliative care",
              "cadence": "From the diagnosis of advanced cancer",
              "status": "completed_today",
              "detail": "Seen every 3 to 4 weeks",
              "guideline_ids": [
                "GL-ASCO-PALL-2017"
              ]
            },
            {
              "domain": "self_management",
              "measure": "Goals of care and advance care planning",
              "cadence": "At diagnosis and at each change in treatment",
              "status": "completed_today",
              "detail": "Goals reviewed with the move to maintenance; agent named at the preventive visit",
              "guideline_ids": [
                "GL-ASCO-PALL-2017"
              ]
            },
            {
              "domain": "self_management",
              "measure": "Vaccination review",
              "cadence": "Yearly and during treatment",
              "status": "completed_today",
              "detail": "Influenza, COVID-19 and PCV20 at the preventive visit; first recombinant zoster dose today",
              "guideline_ids": [
                "GL-CDC-IMZ-2026"
              ]
            }
          ],
          "follow_up": "Cycle 8 day 8 next week. Durvalumab maintenance every 4 weeks from four weeks after today. Second zoster dose in one to two months. Restaging CT in 2 to 3 months",
          "guideline_ids": [
            "GL-NCCN-BIL-2026",
            "GL-TOPAZ1-2022",
            "GL-ASCO-IRAE-2021",
            "GL-ASCO-HBV-2020",
            "GL-ASCO-PALL-2017",
            "GL-CDC-IMZ-2026"
          ]
        }
      },
      {
        "id": "ENC-006",
        "display": "Same-day sick visit for a cold during chemoimmunotherapy",
        "status": "finished",
        "date": "2026-09-02",
        "visit_type": "sick",
        "type_coding": {
          "system": "http://snomed.info/sct",
          "code": "185345009",
          "display": "Encounter for symptom",
          "validation_status": "validated",
          "validated_on": "2026-11-04"
        },
        "documentation": {
          "chief_complaint": "Sore throat, runny nose and cough for three days during chemotherapy",
          "billing_note": "Problem-oriented office visit, established patient",
          "hpi": {
            "narrative": "Mr. Sun called the clinic and was seen the same day. Three days ago he developed a scratchy throat and a runny nose after a week of meetings, and since yesterday a dry cough. He checked his temperature twice a day as taught and the highest was 37.5 °C; he has had no shivering. He is on day 10 of cycle 5 of gemcitabine, cisplatin and durvalumab and had his day-8 infusion two days ago. He is not short of breath, even on the stairs, and has no chest pain, diarrhea, rash, or new abdominal pain. His appetite is a little lower but he is drinking well. Two colleagues at work have colds. He asked whether this could be pneumonitis from durvalumab and whether he needs antibiotics.",
            "elements": [
              {
                "label": "Onset",
                "value": "Three days ago, after colleagues at work had colds"
              },
              {
                "label": "Symptoms",
                "value": "Sore throat, runny nose, dry cough"
              },
              {
                "label": "Temperature",
                "value": "Highest 37.5 °C at home; no shivering"
              },
              {
                "label": "Treatment context",
                "value": "Day 10 of cycle 5 of gemcitabine, cisplatin and durvalumab; day-8 dose two days ago"
              },
              {
                "label": "Associated signs and symptoms",
                "value": "No breathlessness, chest pain, diarrhea, rash, or new abdominal pain"
              },
              {
                "label": "Modifying factors",
                "value": "Warm drinks and honey help the throat"
              }
            ]
          },
          "ros": [
            {
              "system": "Constitutional",
              "status": "positive",
              "finding": "Tired; no fever above 37.5 °C; no shivering"
            },
            {
              "system": "Ears, nose, mouth, and throat",
              "status": "positive",
              "finding": "Sore throat and runny nose; no mouth ulcers"
            },
            {
              "system": "Respiratory",
              "status": "positive",
              "finding": "Dry cough; no breathlessness or sputum"
            },
            {
              "system": "Cardiovascular",
              "status": "negative",
              "finding": "No chest pain or palpitations"
            },
            {
              "system": "Gastrointestinal",
              "status": "negative",
              "finding": "No diarrhea, vomiting, or new abdominal pain"
            },
            {
              "system": "Integumentary",
              "status": "negative",
              "finding": "No rash; port site not sore"
            }
          ],
          "exam": [
            {
              "system": "General",
              "finding": "Tired but well; temperature 37.4 °C, pulse 90, blood pressure 120/76, oxygen saturation 97% on room air, respirations 16"
            },
            {
              "system": "Ears, nose, mouth, and throat",
              "finding": "Red throat without exudate; no mouth ulcers or thrush; clear nasal discharge"
            },
            {
              "system": "Neck",
              "finding": "No tender or enlarged lymph nodes"
            },
            {
              "system": "Respiratory",
              "finding": "Clear to auscultation bilaterally; no crackles or wheeze; oxygen saturation stays at 97% after walking the corridor"
            },
            {
              "system": "Skin",
              "finding": "Port site clean, without redness or tenderness; no rash"
            }
          ],
          "assessment_plan": [
            {
              "problem_id": "PRB-005",
              "display": "Acute viral upper respiratory infection",
              "assessment": "A cold caught from colleagues, with mild neutropenia (1.6 x10^3/uL) expected two days after a day-8 dose and no fever. Rapid SARS-CoV-2 and influenza tests are negative. Pneumonitis from durvalumab is unlikely: the cough is dry and new with cold symptoms, he is not breathless, the lungs are clear, and his oxygen saturation is normal and holds on walking. He has no fever, so this is not febrile neutropenia, and antibiotics would not help",
              "plan": [
                "Fluids, rest, warm drinks with honey, and saline nasal rinses",
                "Acetaminophen as already prescribed; it may mask a fever, so check the temperature before each dose",
                "Call the oncology line at once and go to the emergency department for a temperature of 38.0 °C or higher, shivering, breathlessness, chest pain, or oxygen saturation below 94% on his home meter",
                "Phone check in two days; blood count before cycle 6 as booked"
              ]
            },
            {
              "problem_id": "PRB-002",
              "display": "Gallbladder adenocarcinoma, stage IVB, on chemoimmunotherapy",
              "assessment": "Cycle 6 can go ahead on schedule if the cold has settled and the neutrophil count has recovered, as is usual by day 21",
              "plan": [
                "Dr. Choi's team informed",
                "Cycle 6 day 1 as booked in twelve days"
              ]
            }
          ],
          "follow_up": "Phone check in two days. Cycle 6 day 1 as booked, with the oncology team; preventive visit in about three weeks",
          "guideline_ids": [
            "GL-ASCO-IDSA-FN-2018",
            "GL-ASCO-IRAE-2021",
            "GL-NCCN-BIL-2026"
          ]
        },
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic unscheduled sick visit; the illness is not a historical claim.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "ENC-007",
        "display": "Periodic adult preventive visit",
        "status": "finished",
        "date": "2026-09-21",
        "visit_type": "preventive_adult",
        "type_coding": {
          "system": "http://snomed.info/sct",
          "code": "86013001",
          "display": "Periodic reevaluation and management of healthy individual",
          "validation_status": "validated",
          "validated_on": "2026-11-04"
        },
        "documentation": {
          "chief_complaint": "Periodic adult preventive visit",
          "billing_note": "CPT 99396 (periodic preventive medicine, established patient, age 40 to 64) with CPT 99497 (advance care planning) on the same day",
          "health_risk_assessment_method": "Completed by the patient on the clinic tablet before the visit and reviewed with him by Dr. Huang",
          "hpi": {
            "narrative": "Mr. Sun is a 57-year-old physician by training and political leader who comes for his yearly preventive visit, timed with the day-8 infusion of cycle 6, which he had this morning. The cold of three weeks ago cleared within a week without fever. He has been working most days and has kept his weight steady with the dietitian's advice. He meets the palliative care team every three to four weeks and has talked with them about what matters most to him. He asked which preventive services still make sense for him now, and wants the vaccines that protect him during treatment.",
            "elements": [
              {
                "label": "Visit",
                "value": "Periodic adult preventive visit, age 57"
              },
              {
                "label": "Cancer treatment",
                "value": "Cycle 6 of gemcitabine, cisplatin and durvalumab; day-8 dose today"
              },
              {
                "label": "Recent illness",
                "value": "Cold cleared within a week"
              },
              {
                "label": "Weight",
                "value": "Steady at about 59 kg"
              },
              {
                "label": "His question",
                "value": "Which preventive services still make sense now"
              }
            ]
          },
          "health_risk_assessment": [
            {
              "domain": "Self-rated health",
              "finding": "Fair; tired in the afternoons, but working most days"
            },
            {
              "domain": "Psychosocial",
              "finding": "Supported by colleagues and his household; talks openly with the palliative care team"
            },
            {
              "domain": "Substance use",
              "finding": "Alcohol rarely, at formal dinners; none since starting treatment; no drugs"
            },
            {
              "domain": "Tobacco",
              "finding": "Never smoked"
            },
            {
              "domain": "Physical activity",
              "finding": "Walks 30 minutes most days"
            },
            {
              "domain": "Nutrition",
              "finding": "Small frequent meals and a protein drink each day, as the dietitian advised"
            },
            {
              "domain": "Sleep",
              "finding": "Six to seven hours; occasional night waking"
            },
            {
              "domain": "Infection precautions",
              "finding": "Hand hygiene; avoids crowds in the week after day-8 doses; has a thermometer"
            },
            {
              "domain": "Safety at home",
              "finding": "Feels safe; smoke alarm working; no firearm at home"
            },
            {
              "domain": "Road safety",
              "finding": "Wears a seat belt; is driven to most meetings"
            },
            {
              "domain": "Activities of daily living",
              "finding": "Independent"
            }
          ],
          "ros": [
            {
              "system": "Constitutional",
              "status": "positive",
              "finding": "Afternoon tiredness; no fever; weight steady"
            },
            {
              "system": "Eyes",
              "status": "negative",
              "finding": "Reading glasses; no change"
            },
            {
              "system": "Ears, nose, mouth, and throat",
              "status": "negative",
              "finding": "Cold resolved; no ringing in the ears or hearing change; no mouth sores"
            },
            {
              "system": "Cardiovascular",
              "status": "negative",
              "finding": "No chest pain or leg swelling"
            },
            {
              "system": "Respiratory",
              "status": "negative",
              "finding": "Cough gone; no breathlessness"
            },
            {
              "system": "Gastrointestinal",
              "status": "negative",
              "finding": "Mild nausea on the two days after each infusion, eased by ondansetron; no jaundice; ache under the right ribs 1 of 10"
            },
            {
              "system": "Genitourinary",
              "status": "negative",
              "finding": "No urinary symptoms"
            },
            {
              "system": "Musculoskeletal",
              "status": "negative",
              "finding": "No joint pain"
            },
            {
              "system": "Integumentary",
              "status": "negative",
              "finding": "No rash or itching"
            },
            {
              "system": "Neurological",
              "status": "negative",
              "finding": "No numbness or tingling"
            },
            {
              "system": "Endocrine",
              "status": "negative",
              "finding": "No heat or cold intolerance, thirst, or excess urination"
            },
            {
              "system": "Psychiatric",
              "status": "negative",
              "finding": "Mood steady; PHQ-2 score 1"
            }
          ],
          "exam": [
            {
              "system": "Constitutional",
              "finding": "Thin but well; weight 59.4 kg, BMI 21.8; blood pressure 122/76, pulse 80"
            },
            {
              "system": "Ears, nose, mouth, and throat",
              "finding": "Throat normal; no thrush; whispered voice heard at arm's length in both ears"
            },
            {
              "system": "Respiratory",
              "finding": "Clear to auscultation bilaterally"
            },
            {
              "system": "Abdomen",
              "finding": "Liver edge firm, 2 cm below the right costal margin, smaller than at diagnosis; no ascites; no tenderness"
            },
            {
              "system": "Skin",
              "finding": "Port site clean; no jaundice or rash"
            },
            {
              "system": "Psychiatric",
              "finding": "Composed, engaged, precise in his questions"
            }
          ],
          "assessment_plan": [
            {
              "display": "Periodic adult preventive visit completed",
              "assessment": "Health risk assessment reviewed and the prevention plan adjusted to his advanced cancer, as he asked. Vaccines that protect him during treatment are given today. Cancer screening tests whose benefit takes years to appear (colon, prostate) are not offered now because of his metastatic cancer, after discussion with him. He has never had an HIV test and agreed to one",
              "plan": [
                "Inactivated influenza, COVID-19 and PCV20 pneumococcal vaccines today",
                "First recombinant zoster vaccine dose at the next visit",
                "HIV test today",
                "No live vaccines while on treatment",
                "Next preventive visit in one year"
              ]
            },
            {
              "problem_id": "PRB-002",
              "display": "Gallbladder adenocarcinoma, stage IVB, on chemoimmunotherapy",
              "assessment": "Liver edge smaller on examination; weight steady; ECOG 1. Treatment continues with Dr. Choi",
              "plan": [
                "Cycle 7 as booked; restaging CT after cycle 7"
              ]
            },
            {
              "problem_id": "PRB-005",
              "display": "Acute viral upper respiratory infection",
              "assessment": "Resolved",
              "plan": [
                "No further action"
              ]
            }
          ],
          "prevention_plan": [
            {
              "service": "Blood pressure screening",
              "status": "completed_today",
              "detail": "122/76 mmHg",
              "guideline_ids": [
                "GL-USPSTF-AB"
              ]
            },
            {
              "service": "Depression screening",
              "status": "completed_today",
              "detail": "PHQ-2 score 1; PHQ-9 tracked at oncology visits",
              "guideline_ids": [
                "GL-USPSTF-DEP-2023"
              ]
            },
            {
              "service": "Unhealthy alcohol use screening",
              "status": "completed_today",
              "detail": "Drinks rarely; none since treatment began",
              "guideline_ids": [
                "GL-USPSTF-ALC-2018"
              ]
            },
            {
              "service": "Tobacco use",
              "status": "completed_today",
              "detail": "Never smoked",
              "guideline_ids": [
                "GL-USPSTF-AB"
              ]
            },
            {
              "service": "Colorectal cancer screening",
              "status": "not_indicated",
              "detail": "Never screened; with metastatic gallbladder cancer the benefit of screening would not be realized, and he agreed not to pursue it now",
              "guideline_ids": [
                "GL-USPSTF-CRC-2021"
              ]
            },
            {
              "service": "Prostate cancer screening",
              "status": "not_indicated",
              "detail": "Discussed; not offered while he has metastatic cancer",
              "guideline_ids": [
                "GL-USPSTF-PROSTATE-2018"
              ]
            },
            {
              "service": "Lung cancer screening",
              "status": "not_indicated",
              "detail": "Never smoked; he has CT scans of the chest every 2 to 3 months for his cancer",
              "guideline_ids": [
                "GL-USPSTF-AB"
              ]
            },
            {
              "service": "Diabetes screening",
              "status": "not_indicated",
              "detail": "Not overweight; glucose 98 mg/dL at intake",
              "guideline_ids": [
                "GL-USPSTF-AB"
              ]
            },
            {
              "service": "HIV screening",
              "status": "ordered",
              "detail": "Never tested; once-in-a-lifetime test drawn today with his agreement",
              "guideline_ids": [
                "GL-USPSTF-HIV-2019"
              ]
            },
            {
              "service": "Hepatitis C screening",
              "status": "up_to_date",
              "detail": "Antibody negative at intake",
              "guideline_ids": [
                "GL-USPSTF-HCV-2020"
              ]
            },
            {
              "service": "Hepatitis B screening",
              "status": "up_to_date",
              "detail": "Resolved infection at intake; HBV DNA monitored during treatment; vaccination not needed",
              "guideline_ids": [
                "GL-CDC-IMZ-2026",
                "GL-ASCO-HBV-2020"
              ]
            },
            {
              "service": "Influenza vaccine",
              "status": "completed_today",
              "detail": "Inactivated vaccine given today",
              "guideline_ids": [
                "GL-CDC-IMZ-2026"
              ]
            },
            {
              "service": "COVID-19 vaccine",
              "status": "completed_today",
              "detail": "Given today; immunocompromised adults may need an additional dose, to be reviewed with the oncology team",
              "guideline_ids": [
                "GL-CDC-IMZ-2026"
              ]
            },
            {
              "service": "Pneumococcal vaccine",
              "status": "completed_today",
              "detail": "PCV20 given today because chemotherapy suppresses his immunity; no further pneumococcal dose needed",
              "guideline_ids": [
                "GL-CDC-IMZ-2026"
              ]
            },
            {
              "service": "Zoster vaccine",
              "status": "due",
              "detail": "Recombinant zoster vaccine recommended for immunocompromised adults; first dose at the next visit, second one to two months later",
              "guideline_ids": [
                "GL-CDC-IMZ-2026"
              ]
            },
            {
              "service": "Tetanus, diphtheria, and pertussis",
              "status": "up_to_date",
              "detail": "Tdap after a hand cut five years ago",
              "guideline_ids": [
                "GL-CDC-IMZ-2026"
              ]
            }
          ],
          "advance_care_planning": "Voluntary advance care planning discussion of about 25 minutes, with his consent, building on his conversations with the palliative care team. He named a health care agent, recorded in the confidential part of the chart and not named here. He wants to be told everything plainly and to make his own decisions while he can. He wants treatment that lets him keep working and thinking clearly; if his illness reached the point where he could no longer communicate and there was no prospect of recovery, he would not want to be kept alive on machines and would want comfort care. He chose to wait before completing a portable medical order form and will revisit it with the palliative care team. To be revisited when treatment changes.",
          "follow_up": "HIV result by phone. Cycle 7 as booked. Oncology visit before cycle 8 with restaging CT; first zoster vaccine dose then. Next preventive visit in one year",
          "guideline_ids": [
            "GL-PREV-2026",
            "GL-USPSTF-AB",
            "GL-CDC-IMZ-2026",
            "GL-USPSTF-CRC-2021",
            "GL-ASCO-PALL-2017"
          ]
        },
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic periodic preventive visit.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      }
    ],
    "vital_sign_sets": [
      {
        "id": "VSET-001",
        "date": "2026-05-04",
        "measurements": [
          {
            "code": "8302-2",
            "display": "Body height",
            "value": 165,
            "unit": "cm"
          },
          {
            "code": "29463-7",
            "display": "Body weight",
            "value": 61.0,
            "unit": "kg"
          },
          {
            "code": "39156-5",
            "display": "Body mass index (BMI) [Ratio]",
            "value": 22.4,
            "unit": "kg/m2"
          },
          {
            "code": "8480-6",
            "display": "Systolic blood pressure",
            "value": 132,
            "unit": "mm[Hg]"
          },
          {
            "code": "8462-4",
            "display": "Diastolic blood pressure",
            "value": 84,
            "unit": "mm[Hg]"
          },
          {
            "code": "8867-4",
            "display": "Heart rate",
            "value": 88,
            "unit": "/min"
          },
          {
            "code": "9279-1",
            "display": "Respiratory rate",
            "value": 16,
            "unit": "/min"
          },
          {
            "code": "8310-5",
            "display": "Body temperature",
            "value": 36.9,
            "unit": "Cel"
          },
          {
            "code": "59408-5",
            "display": "Oxygen saturation in Arterial blood by Pulse oximetry",
            "value": 98,
            "unit": "%"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic seated vital signs; no measurement from his lifetime is used.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "VSET-002",
        "date": "2026-05-18",
        "measurements": [
          {
            "code": "8302-2",
            "display": "Body height",
            "value": 165,
            "unit": "cm"
          },
          {
            "code": "29463-7",
            "display": "Body weight",
            "value": 60.6,
            "unit": "kg"
          },
          {
            "code": "39156-5",
            "display": "Body mass index (BMI) [Ratio]",
            "value": 22.3,
            "unit": "kg/m2"
          },
          {
            "code": "8480-6",
            "display": "Systolic blood pressure",
            "value": 128,
            "unit": "mm[Hg]"
          },
          {
            "code": "8462-4",
            "display": "Diastolic blood pressure",
            "value": 82,
            "unit": "mm[Hg]"
          },
          {
            "code": "8867-4",
            "display": "Heart rate",
            "value": 86,
            "unit": "/min"
          },
          {
            "code": "9279-1",
            "display": "Respiratory rate",
            "value": 16,
            "unit": "/min"
          },
          {
            "code": "8310-5",
            "display": "Body temperature",
            "value": 36.8,
            "unit": "Cel"
          },
          {
            "code": "59408-5",
            "display": "Oxygen saturation in Arterial blood by Pulse oximetry",
            "value": 98,
            "unit": "%"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic seated vital signs; no measurement from his lifetime is used.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "VSET-003",
        "date": "2026-06-01",
        "measurements": [
          {
            "code": "8302-2",
            "display": "Body height",
            "value": 165,
            "unit": "cm"
          },
          {
            "code": "29463-7",
            "display": "Body weight",
            "value": 60.0,
            "unit": "kg"
          },
          {
            "code": "39156-5",
            "display": "Body mass index (BMI) [Ratio]",
            "value": 22.0,
            "unit": "kg/m2"
          },
          {
            "code": "8480-6",
            "display": "Systolic blood pressure",
            "value": 126,
            "unit": "mm[Hg]"
          },
          {
            "code": "8462-4",
            "display": "Diastolic blood pressure",
            "value": 80,
            "unit": "mm[Hg]"
          },
          {
            "code": "8867-4",
            "display": "Heart rate",
            "value": 84,
            "unit": "/min"
          },
          {
            "code": "9279-1",
            "display": "Respiratory rate",
            "value": 16,
            "unit": "/min"
          },
          {
            "code": "8310-5",
            "display": "Body temperature",
            "value": 36.7,
            "unit": "Cel"
          },
          {
            "code": "59408-5",
            "display": "Oxygen saturation in Arterial blood by Pulse oximetry",
            "value": 98,
            "unit": "%"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic seated vital signs; no measurement from his lifetime is used.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "VSET-004",
        "date": "2026-08-03",
        "measurements": [
          {
            "code": "8302-2",
            "display": "Body height",
            "value": 165,
            "unit": "cm"
          },
          {
            "code": "29463-7",
            "display": "Body weight",
            "value": 59.2,
            "unit": "kg"
          },
          {
            "code": "39156-5",
            "display": "Body mass index (BMI) [Ratio]",
            "value": 21.7,
            "unit": "kg/m2"
          },
          {
            "code": "8480-6",
            "display": "Systolic blood pressure",
            "value": 122,
            "unit": "mm[Hg]"
          },
          {
            "code": "8462-4",
            "display": "Diastolic blood pressure",
            "value": 78,
            "unit": "mm[Hg]"
          },
          {
            "code": "8867-4",
            "display": "Heart rate",
            "value": 82,
            "unit": "/min"
          },
          {
            "code": "9279-1",
            "display": "Respiratory rate",
            "value": 16,
            "unit": "/min"
          },
          {
            "code": "8310-5",
            "display": "Body temperature",
            "value": 36.6,
            "unit": "Cel"
          },
          {
            "code": "59408-5",
            "display": "Oxygen saturation in Arterial blood by Pulse oximetry",
            "value": 98,
            "unit": "%"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic seated vital signs; no measurement from his lifetime is used.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "VSET-005",
        "date": "2026-10-26",
        "measurements": [
          {
            "code": "8302-2",
            "display": "Body height",
            "value": 165,
            "unit": "cm"
          },
          {
            "code": "29463-7",
            "display": "Body weight",
            "value": 59.6,
            "unit": "kg"
          },
          {
            "code": "39156-5",
            "display": "Body mass index (BMI) [Ratio]",
            "value": 21.9,
            "unit": "kg/m2"
          },
          {
            "code": "8480-6",
            "display": "Systolic blood pressure",
            "value": 124,
            "unit": "mm[Hg]"
          },
          {
            "code": "8462-4",
            "display": "Diastolic blood pressure",
            "value": 78,
            "unit": "mm[Hg]"
          },
          {
            "code": "8867-4",
            "display": "Heart rate",
            "value": 80,
            "unit": "/min"
          },
          {
            "code": "9279-1",
            "display": "Respiratory rate",
            "value": 16,
            "unit": "/min"
          },
          {
            "code": "8310-5",
            "display": "Body temperature",
            "value": 36.6,
            "unit": "Cel"
          },
          {
            "code": "59408-5",
            "display": "Oxygen saturation in Arterial blood by Pulse oximetry",
            "value": 98,
            "unit": "%"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic seated vital signs; no measurement from his lifetime is used.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "VSET-006",
        "date": "2026-09-02",
        "measurements": [
          {
            "code": "8302-2",
            "display": "Body height",
            "value": 165,
            "unit": "cm"
          },
          {
            "code": "29463-7",
            "display": "Body weight",
            "value": 59.0,
            "unit": "kg"
          },
          {
            "code": "39156-5",
            "display": "Body mass index (BMI) [Ratio]",
            "value": 21.7,
            "unit": "kg/m2"
          },
          {
            "code": "8480-6",
            "display": "Systolic blood pressure",
            "value": 120,
            "unit": "mm[Hg]"
          },
          {
            "code": "8462-4",
            "display": "Diastolic blood pressure",
            "value": 76,
            "unit": "mm[Hg]"
          },
          {
            "code": "8867-4",
            "display": "Heart rate",
            "value": 90,
            "unit": "/min"
          },
          {
            "code": "9279-1",
            "display": "Respiratory rate",
            "value": 16,
            "unit": "/min"
          },
          {
            "code": "8310-5",
            "display": "Body temperature",
            "value": 37.4,
            "unit": "Cel"
          },
          {
            "code": "59408-5",
            "display": "Oxygen saturation in Arterial blood by Pulse oximetry",
            "value": 97,
            "unit": "%"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic vital signs at the sick visit.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "VSET-007",
        "date": "2026-09-21",
        "measurements": [
          {
            "code": "8302-2",
            "display": "Body height",
            "value": 165,
            "unit": "cm"
          },
          {
            "code": "29463-7",
            "display": "Body weight",
            "value": 59.4,
            "unit": "kg"
          },
          {
            "code": "39156-5",
            "display": "Body mass index (BMI) [Ratio]",
            "value": 21.8,
            "unit": "kg/m2"
          },
          {
            "code": "8480-6",
            "display": "Systolic blood pressure",
            "value": 122,
            "unit": "mm[Hg]"
          },
          {
            "code": "8462-4",
            "display": "Diastolic blood pressure",
            "value": 76,
            "unit": "mm[Hg]"
          },
          {
            "code": "8867-4",
            "display": "Heart rate",
            "value": 80,
            "unit": "/min"
          },
          {
            "code": "9279-1",
            "display": "Respiratory rate",
            "value": 16,
            "unit": "/min"
          },
          {
            "code": "8310-5",
            "display": "Body temperature",
            "value": 36.6,
            "unit": "Cel"
          },
          {
            "code": "59408-5",
            "display": "Oxygen saturation in Arterial blood by Pulse oximetry",
            "value": 98,
            "unit": "%"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic seated vital signs at the preventive visit.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      }
    ],
    "social_history": [
      {
        "id": "SOC-001",
        "display": "Physician by training: studied Western medicine in Guangzhou and Hong Kong and practiced for about two years in Macau and Guangzhou before leaving medicine for public life decades ago; now leads a national political organization, writes and speaks widely, and travels often",
        "status": "current",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0003",
            "CLM-0004",
            "CLM-0005"
          ],
          "synthetic_reason": "Synthetic modern work history anchored to his documented medical training, brief practice, and political career.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "SOC-002",
        "display": "Never smoked; drinks alcohol rarely, at formal dinners; no other substance use",
        "status": "current",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic history; not a claim about his real habits.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "SOC-003",
        "display": "Lives with his wife in a rented apartment near his organization's offices; he chooses who joins him at visits and what they are told. Speaks Cantonese, Mandarin and English and chose English for his visits; an interpreter is offered for any family meeting",
        "status": "current",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic social history; no decision, statement or health fact is attributed to any real relative.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "SOC-004",
        "display": "Strengths and supports: a clear, analytical mind and his own medical training; a strong sense of purpose in his work; a wide circle of colleagues",
        "status": "current",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0003",
            "CLM-0005"
          ],
          "synthetic_reason": "Synthetic strengths anchored to his documented training and career.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      }
    ],
    "functional_status": [
      {
        "id": "FUNC-001",
        "display": "Independent in all activities; still works full days but tires by evening; walks 2 km without stopping",
        "status": "current",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic functional status (ECOG 1).",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      }
    ],
    "mental_status": [
      {
        "id": "MSE-001",
        "display": "Alert, composed and precise; asks to see the ultrasound images himself; worried that the mass is a cancer; PHQ-2 1",
        "status": "current",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic mental-status finding.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      }
    ],
    "consultation": {
      "referral": {
        "question": "A solid 6.8 cm mass in liver segments IV and V, inseparable from a gallbladder containing stones, in a 57-year-old man with three months of right upper abdominal aching, early fullness and 4 kg weight loss. He trained and briefly practiced as a physician. Multiphase CT, tumor markers and hepatitis serology are under way. Please establish the diagnosis, stage the disease, take him to the tumor board, and advise on treatment",
        "urgency": "Within two weeks, with the CT and any biopsy result",
        "pertinent_history": "Dull ache under the right ribs and early fullness for about three months; 4 kg weight loss; no jaundice, fever, itching or vomiting. Examination: a firm, non-tender mass 4 cm below the right costal margin; no ascites or nodes. Ultrasound today: a 6.8 cm solid, heterogeneous mass in segments IV and V that cannot be separated from the gallbladder, which contains stones; the rest of the liver smooth. Results today: hemoglobin 12.6 g/dL, platelets 342 x10^3/uL, creatinine 0.86 mg/dL, albumin 3.4 g/dL, bilirubin 0.9 mg/dL, alkaline phosphatase 212 U/L, AST 48 U/L, ALT 41 U/L, INR 1.0, alpha-fetoprotein 3.2 ng/mL, CA 19-9 412 U/mL, CEA 8.6 ng/mL. Hepatitis B and C serology sent. Never smoked; alcohol rarely. Acetaminophen as needed. No known allergies. ECOG 1. He leads a political organization and works full days. As a physician by training he asks to see his images and results, wants plain information, and wants to be cared for on the standard pathway",
        "questions": [
          "Is this a primary liver cancer, a gallbladder or other biliary cancer, or a metastasis, and what tissue diagnosis is needed?",
          "What further staging is needed, and is the tumor resectable?",
          "How do his liver function and hepatitis B and C status affect the options?",
          "What treatment do you advise, and how should it be planned with the multidisciplinary tumor board?",
          "When should specialist palliative care join, and how should results be shared with a patient who is himself a physician?"
        ]
      },
      "consultant_note": {
        "history": "Mr. Sun, a 57-year-old political leader who trained and briefly practiced in medicine, is seen at the request of Dr. Huang two weeks after presenting with three months of right upper abdominal aching, early fullness and 4 kg weight loss and a palpable mass. He has had a multiphase CT, MRI with MRCP and an ultrasound-guided core biopsy. He has no jaundice, itching, fever or vomiting, and works full days. He reviewed the images with us and asked for a plain account",
        "data_reviewed": "Multiphase CT of the liver with CT of the chest, abdomen and pelvis: a 7.1 cm mass arising from the gallbladder fundus and invading liver segments IVb and V, gallstones, two enlarged hepatoduodenal ligament nodes (1.6 and 1.3 cm), main portal vein and hepatic artery free, no other liver lesions, no ascites, a 6 mm calcified granuloma in the right upper lobe. MRI with MRCP: the mass arises from the gallbladder wall; no bile duct dilation; liver smooth without cirrhosis. Core biopsy: moderately differentiated adenocarcinoma, CK7 positive, CK20 and CDX2 negative. Alpha-fetoprotein 3.2 ng/mL, CA 19-9 412 U/mL, CEA 8.6 ng/mL. Albumin 3.4 g/dL, bilirubin 0.9 mg/dL, INR 1.0, creatinine 0.86 mg/dL. Hepatitis B surface antigen negative, core antibody positive, surface antibody 85 mIU/mL, HBV DNA undetectable; hepatitis C antibody negative",
        "exam": [
          {
            "system": "General",
            "finding": "Thin, alert, no jaundice; blood pressure 128/82, pulse 86; ECOG 1"
          },
          {
            "system": "Abdomen",
            "finding": "Firm, non-tender mass 4 cm below the right costal margin, moving with breathing; no ascites"
          },
          {
            "system": "Lymph nodes",
            "finding": "No supraclavicular or umbilical nodes"
          }
        ],
        "assessment": [
          {
            "problem_id": "PRB-002",
            "display": "Adenocarcinoma of the gallbladder invading the liver",
            "assessment": "This is not a primary liver cancer. In a liver without cirrhosis the imaging criteria for hepatocellular carcinoma do not apply and tissue is needed; the biopsy shows an adenocarcinoma with a pancreatobiliary pattern, the imaging shows it arising from the gallbladder wall, and alpha-fetoprotein is normal. This is a primary gallbladder adenocarcinoma invading the liver, clinical T3 N1 M0 (stage IIIB) on imaging. Gallbladder cancer often has peritoneal spread that CT does not show, so a staging laparoscopy should come before any attempt at resection. If there is no metastatic disease, an extended cholecystectomy with resection of segments IVb and V and portal lymphadenectomy could be curative in intent; if there is, treatment is systemic: gemcitabine and cisplatin with durvalumab is the preferred first-line regimen. Genomic profiling of the biopsy now will save time if a targeted treatment becomes relevant"
          },
          {
            "problem_id": "PRB-003",
            "display": "Resolved hepatitis B infection",
            "assessment": "Resolved past infection with undetectable HBV DNA and preserved liver function (Child-Pugh A6, ALBI grade 2). It does not limit surgery or chemotherapy. The reactivation risk with gemcitabine, cisplatin and durvalumab is low to moderate; monitoring HBV DNA and ALT every 3 months, with entecavir if HBV DNA becomes detectable, is appropriate. Hepatitis C is excluded"
          }
        ],
        "recommendations": [
          "Multidisciplinary hepatobiliary tumor board review this week",
          "Staging laparoscopy before any resection, with biopsy of any peritoneal disease and an implanted port placed under the same anesthetic",
          "If there are no metastases: extended cholecystectomy with resection of liver segments IVb and V and portal lymphadenectomy, then adjuvant treatment; if there are metastases: gemcitabine 1,000 mg/m2 and cisplatin 25 mg/m2 on days 1 and 8 with durvalumab 1,500 mg on day 1 every 21 days for up to 8 cycles, then durvalumab every 4 weeks",
          "Comprehensive genomic profiling of the biopsy tissue now (HER2, mismatch repair and microsatellite status, FGFR2, IDH1, BRAF, NTRK, RET, KRAS, tumor mutational burden)",
          "HBV DNA and ALT every 3 months during treatment and for 6 to 12 months after, with entecavir if HBV DNA becomes detectable or surface antigen reappears",
          "Specialist palliative care alongside treatment as soon as advanced disease is confirmed, or earlier if he wishes",
          "Results shared with him in full and in person, with his images, by one coordinating clinician; the same pathway and the same thresholds as for any patient"
        ],
        "communication": "Discussed with Dr. Huang, who sees him the same day. Mr. Sun reviewed the images and the pathology with us. We explained why a staging laparoscopy comes before any operation, what each result would mean for treatment, and that the aim of treatment would be decided by that result. He asked to hear results himself first and to decide who else is told; he agreed to the plan. He decides who receives this note",
        "follow_up": "Tumor board this week; staging laparoscopy in about ten days; review with Dr. Huang and the oncology team in two weeks with the result to decide treatment"
      },
      "guideline_ids": [
        "GL-NCCN-BIL-2026",
        "GL-AASLD-HCC-2023",
        "GL-TOPAZ1-2022",
        "GL-ASCO-HBV-2020",
        "GL-ASCO-PALL-2017"
      ]
    }
  },
  "care_plan": {
    "health_concerns": [
      {
        "id": "HC-001",
        "display": "He has had a dull ache under his right ribs, early fullness and weight loss for three months, and can feel a firm lump there himself",
        "status": "active",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0007"
          ],
          "synthetic_reason": "Synthetic patient-centered concern anchored to the documented abdominal mass.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "HC-002",
        "display": "As a physician by training he wants to see his images and results himself, to be told plainly, and to be cared for on the same pathway as any other patient",
        "status": "active",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0003"
          ],
          "synthetic_reason": "Synthetic patient-centered concern anchored to his documented medical training.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "HC-003",
        "display": "He wants to keep working and traveling for as long as he can",
        "status": "active",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0005"
          ],
          "synthetic_reason": "Synthetic patient-centered concern anchored to his documented career.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      }
    ],
    "goals": [
      {
        "id": "GOAL-001",
        "display": "Tissue diagnosis and complete staging within four weeks of the first visit",
        "status": "completed",
        "target_date": "2026-06-01",
        "outcome": "Biopsy diagnosis in nine days and staging complete by laparoscopy in about three and a half weeks",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic diagnostic goal.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "GOAL-002",
        "display": "Right upper abdominal pain at 3 of 10 or less, with full days of work possible (ECOG 0 to 1)",
        "status": "completed",
        "target_date": "2026-10-26",
        "outcome": "Ache 0 to 2 of 10 on acetaminophen as needed; ECOG 1 throughout",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic symptom goal set with him.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "GOAL-003",
        "display": "Weight held within 2 kg of the weight at the start of treatment",
        "status": "completed",
        "target_date": "2026-10-26",
        "outcome": "60.0 kg at cycle 1 and 59.6 kg at cycle 8",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic nutrition goal.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "GOAL-004",
        "display": "Goals of care and a health care agent documented, and revisited as treatment changes",
        "status": "completed",
        "target_date": "2026-09-21",
        "outcome": "Agent named and goals recorded with palliative care and at the preventive visit",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic advance care planning goal.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "GOAL-005",
        "display": "Complete first-line chemoimmunotherapy without grade 3 or higher toxicity",
        "status": "active",
        "target_date": "2026-10-26",
        "outcome": "Seven cycles given by the last visit with grade 1 toxicity only; the eighth started that day",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic treatment goal.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      }
    ],
    "interventions": [
      {
        "id": "INT-001",
        "display": "Work-up of the liver mass: multiphase contrast CT of the liver with CT of the chest, abdomen and pelvis; MRI of the liver with MRCP if CT does not settle the origin; alpha-fetoprotein, CA 19-9 and CEA; hepatitis B surface antigen, core antibody and surface antibody, and hepatitis C antibody; liver function with Child-Pugh and ALBI scoring; and image-guided core biopsy, because a mass in a liver without cirrhosis cannot be diagnosed by imaging alone",
        "status": "completed",
        "guideline_ids": [
          "GL-AASLD-HCC-2023",
          "GL-NCCN-BIL-2026"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0007"
          ],
          "synthetic_reason": "Synthetic diagnostic plan.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "INT-002",
        "display": "Medical oncology consultation for a solid liver mass with weight loss: diagnosis, staging, multidisciplinary tumor board review, and treatment",
        "status": "completed",
        "guideline_ids": [
          "GL-NCCN-BIL-2026",
          "GL-AASLD-HCC-2023"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0007"
          ],
          "synthetic_reason": "Synthetic specialist referral.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "INT-003",
        "display": "Symptom care during the work-up: acetaminophen up to 3,000 mg a day, small frequent meals with a dietitian's advice, weight at every visit, and a same-day call for jaundice, fever, vomiting, dark urine or worse pain; results shared with him in full as they arrive, by one coordinating clinician",
        "status": "completed",
        "guideline_ids": [
          "GL-NCCN-BIL-2026"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic symptom and communication plan.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "INT-004",
        "display": "Staging laparoscopy before any attempt at resection, with biopsy of any peritoneal disease and an implanted port under the same anesthetic; if no metastases, extended cholecystectomy with resection of liver segments IVb and V and portal lymphadenectomy; comprehensive genomic profiling of the biopsy tissue (HER2, mismatch repair and microsatellite status, BRAF, FGFR2, IDH1, NTRK, RET, KRAS, tumor mutational burden)",
        "status": "completed",
        "guideline_ids": [
          "GL-NCCN-BIL-2026"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0007",
            "CLM-0008",
            "CLM-0010",
            "CLM-0011"
          ],
          "synthetic_reason": "Synthetic staging and surgical plan decided at the consultation.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        },
        "recorded_date": "2026-05-18"
      },
      {
        "id": "INT-005",
        "display": "Hepatitis B reactivation monitoring for resolved infection (surface antigen negative, core antibody positive, HBV DNA undetectable): HBV DNA and ALT every 3 months during treatment and for at least 6 to 12 months after, with entecavir started promptly if HBV DNA becomes detectable or surface antigen reappears",
        "status": "completed",
        "guideline_ids": [
          "GL-ASCO-HBV-2020"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic monitoring plan decided when the serology was reviewed.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        },
        "recorded_date": "2026-05-18"
      },
      {
        "id": "INT-006",
        "display": "First-line systemic therapy for stage IVB gallbladder adenocarcinoma: gemcitabine 1,000 mg/m2 and cisplatin 25 mg/m2 on days 1 and 8 with durvalumab 1,500 mg on day 1 every 21 days for up to 8 cycles, then durvalumab 1,500 mg every 4 weeks until progression or unacceptable toxicity; blood count, creatinine, magnesium and liver tests before each dose; TSH every cycle; CA 19-9 each cycle; CT of the chest, abdomen and pelvis every 2 to 3 months; teaching on immune-related side effects; ondansetron at home",
        "status": "completed",
        "guideline_ids": [
          "GL-NCCN-BIL-2026",
          "GL-TOPAZ1-2022",
          "GL-ASCO-IRAE-2021"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0007",
            "CLM-0008",
            "CLM-0010",
            "CLM-0011"
          ],
          "synthetic_reason": "Synthetic treatment plan decided after the staging laparoscopy and tumor board.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        },
        "recorded_date": "2026-06-01"
      },
      {
        "id": "INT-007",
        "display": "Specialist palliative care alongside cancer treatment from the diagnosis of advanced disease: symptoms, nutrition, coping, goals of care, a health care agent, and a family meeting if and when he chooses",
        "status": "completed",
        "guideline_ids": [
          "GL-ASCO-PALL-2017"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic palliative care plan decided once stage IVB disease was confirmed.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        },
        "recorded_date": "2026-06-01"
      },
      {
        "id": "INT-008",
        "display": "Magnesium oxide 400 mg by mouth daily for cisplatin-related low magnesium, rechecked with each dose; durvalumab maintenance every 4 weeks after the eighth cycle, with restaging CT every 2 to 3 months",
        "status": "completed",
        "guideline_ids": [
          "GL-NCCN-BIL-2026",
          "GL-TOPAZ1-2022"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic plan decided before the eighth cycle.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        },
        "recorded_date": "2026-10-26"
      }
    ],
    "guidelines": [
      {
        "guideline_id": "GL-NCCN-BIL-2026",
        "title": "NCCN Clinical Practice Guidelines in Oncology: Biliary Tract Cancers",
        "publisher": "National Comprehensive Cancer Network",
        "url": "https://www.nccn.org/guidelines/guidelines-detail?category=1&id=1517",
        "version_or_year": "2026"
      },
      {
        "guideline_id": "GL-AASLD-HCC-2023",
        "title": "AASLD Practice Guidance on prevention, diagnosis, and treatment of hepatocellular carcinoma",
        "publisher": "American Association for the Study of Liver Diseases (Hepatology)",
        "url": "https://pubmed.ncbi.nlm.nih.gov/37199193/",
        "version_or_year": "2023"
      },
      {
        "guideline_id": "GL-TOPAZ1-2022",
        "title": "Durvalumab plus Gemcitabine and Cisplatin in Advanced Biliary Tract Cancer (TOPAZ-1)",
        "publisher": "NEJM Evidence",
        "url": "https://pubmed.ncbi.nlm.nih.gov/38319896/",
        "version_or_year": "2022"
      },
      {
        "guideline_id": "GL-ASCO-HBV-2020",
        "title": "Hepatitis B Virus Screening and Management for Patients With Cancer Prior to Therapy: ASCO Provisional Clinical Opinion Update",
        "publisher": "American Society of Clinical Oncology (Journal of Clinical Oncology)",
        "url": "https://pubmed.ncbi.nlm.nih.gov/32716741/",
        "version_or_year": "2020"
      },
      {
        "guideline_id": "GL-ASCO-PALL-2017",
        "title": "Integration of Palliative Care Into Standard Oncology Care: American Society of Clinical Oncology Clinical Practice Guideline Update",
        "publisher": "American Society of Clinical Oncology (Journal of Clinical Oncology)",
        "url": "https://pubmed.ncbi.nlm.nih.gov/28034065/",
        "version_or_year": "2017"
      },
      {
        "guideline_id": "GL-ASCO-IRAE-2021",
        "title": "Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: ASCO Guideline Update",
        "publisher": "American Society of Clinical Oncology (Journal of Clinical Oncology)",
        "url": "https://pubmed.ncbi.nlm.nih.gov/34724392/",
        "version_or_year": "2021"
      },
      {
        "guideline_id": "GL-ASCO-IDSA-FN-2018",
        "title": "Outpatient Management of Fever and Neutropenia in Adults Treated for Malignancy: American Society of Clinical Oncology and Infectious Diseases Society of America Clinical Practice Guideline Update",
        "publisher": "American Society of Clinical Oncology and Infectious Diseases Society of America (Journal of Clinical Oncology)",
        "url": "https://pubmed.ncbi.nlm.nih.gov/29461916/",
        "version_or_year": "2018"
      },
      {
        "guideline_id": "GL-PREV-2026",
        "title": "Medicare Preventive Services reference: visit templates, screening cascades, and documentation elements",
        "publisher": "Aether Forge",
        "url": "https://patrickrutledge.github.io/preventative_services/",
        "version_or_year": "2026"
      },
      {
        "guideline_id": "GL-USPSTF-AB",
        "title": "USPSTF A and B Recommendations",
        "publisher": "U.S. Preventive Services Task Force",
        "url": "https://www.uspreventiveservicestaskforce.org/uspstf/recommendation-topics/uspstf-a-and-b-recommendations",
        "version_or_year": "2026"
      },
      {
        "guideline_id": "GL-USPSTF-CRC-2021",
        "title": "Colorectal Cancer: Screening",
        "publisher": "U.S. Preventive Services Task Force",
        "url": "https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/colorectal-cancer-screening",
        "version_or_year": "2021"
      },
      {
        "guideline_id": "GL-USPSTF-PROSTATE-2018",
        "title": "Prostate Cancer: Screening",
        "publisher": "U.S. Preventive Services Task Force",
        "url": "https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/prostate-cancer-screening",
        "version_or_year": "2018"
      },
      {
        "guideline_id": "GL-USPSTF-ALC-2018",
        "title": "Unhealthy Alcohol Use in Adolescents and Adults: Screening and Behavioral Counseling Interventions",
        "publisher": "U.S. Preventive Services Task Force",
        "url": "https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/unhealthy-alcohol-use-in-adolescents-and-adults-screening-and-behavioral-counseling-interventions",
        "version_or_year": "2018"
      },
      {
        "guideline_id": "GL-USPSTF-DEP-2023",
        "title": "Depression and Suicide Risk in Adults: Screening",
        "publisher": "U.S. Preventive Services Task Force",
        "url": "https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/screening-depression-suicide-risk-adults",
        "version_or_year": "2023"
      },
      {
        "guideline_id": "GL-USPSTF-HIV-2019",
        "title": "Human Immunodeficiency Virus (HIV) Infection: Screening",
        "publisher": "U.S. Preventive Services Task Force",
        "url": "https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/human-immunodeficiency-virus-hiv-infection-screening",
        "version_or_year": "2019"
      },
      {
        "guideline_id": "GL-USPSTF-HCV-2020",
        "title": "Hepatitis C Virus Infection in Adolescents and Adults: Screening",
        "publisher": "U.S. Preventive Services Task Force",
        "url": "https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/hepatitis-c-screening",
        "version_or_year": "2020"
      },
      {
        "guideline_id": "GL-CDC-IMZ-2026",
        "title": "Adult Immunization Schedule by Medical Condition and Other Indication",
        "publisher": "Centers for Disease Control and Prevention",
        "url": "https://www.cdc.gov/vaccines/hcp/imz-schedules/adult-medical-condition.html",
        "version_or_year": "2026"
      }
    ]
  },
  "review": {
    "schema_validation": {
      "status": "not_started",
      "notes": "Run scripts/build.ps1 -Conformance."
    },
    "clinical_review": {
      "status": "not_started",
      "notes": "Awaiting clinician review; check the liver-mass work-up in a non-cirrhotic liver (biopsy rather than imaging criteria), the gallbladder primary, the staging laparoscopy, gemcitabine, cisplatin and durvalumab dosing and monitoring, hepatitis B monitoring rather than prophylaxis for resolved infection, and the timing of palliative care."
    },
    "provenance_review": {
      "status": "not_started",
      "notes": "Barth and Chen 2016 (PMC5009495), the Museum of Dr. Sun Yat-sen biography and chronology, Chow 2007 (The Hong Kong Practitioner), and the Tianjin University biography of Liu Ruiheng logged. The liver cancer and gallbladder cancer accounts are both recorded as R claims."
    },
    "safe_messaging_review": {
      "status": "not_started",
      "notes": "A national founding figure; the modern episode adds no claim about his real health beyond the cited sources, his hepatitis B serology is labeled synthetic, and no decision or statement is attributed to his wife or other real people. His death is recorded as history only."
    }
  }
}
